Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,35728,94,1.23 [0.39-3.87],0.7192549815983242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,34734,94,0.68 [0.46-1.00],0.0502542590285218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,40836,112,1.19 [0.88-1.59],0.2557920795291348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,34553,90,1.05 [0.60-1.83],0.8691384169802295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,40590,108,1.05 [0.78-1.42],0.7375836280738519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,40836,112,0.96 [0.75-1.24],0.7600156616552873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,35700,95,1.07 [0.94-1.23],0.3178305679615969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,34553,90,0.75 [0.54-1.03],0.0778628223157217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",35024,96,1.06 [0.82-1.37],0.6511802354477213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",35675,94,0.88 [0.70-1.11],0.2878302667317531
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,40627,111,1.44 [0.78-2.66],0.2393118924922183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,35700,95,1.12 [0.54-2.35],0.7549180955600943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,40303,112,0.88 [0.69-1.11],0.2814657701109894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,34912,91,1.60 [0.93-2.75],0.0893813333780725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,35524,95,0.90 [0.76-1.08],0.256316373146101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,34646,90,1.15 [0.75-1.76],0.5239756653023381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,41215,114,1.04 [0.63-1.71],0.8724730657999737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,41340,112,1.05 [0.81-1.35],0.7146837279228895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,35515,96,0.53 [0.30-0.93],0.0267858909959559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,34646,90,1.10 [0.85-1.43],0.4673828128013938
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,34553,90,1.08 [0.65-1.81],0.7652838611357655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",40303,112,0.81 [0.53-1.25],0.3427525533845466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,34553,90,1.11 [0.80-1.54],0.5425993302310061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,40296,112,1.14 [0.71-1.83],0.5840718308306204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,40657,108,1.26 [0.94-1.69],0.1175646808385894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34553,90,1.24 [0.87-1.77],0.2298841931733025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,34781,91,0.97 [0.71-1.32],0.8425922354561467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,41497,113,0.81 [0.50-1.32],0.4014755101324301
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34646,90,1.15 [0.66-2.01],0.6241037506610615
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40303,112,0.69 [0.39-1.20],0.1837842548448433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40726,108,1.54 [0.95-2.49],0.0801177818416245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41497,113,1.15 [0.70-1.87],0.5815327383903703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41321,112,1.21 [0.66-2.20],0.5433986372267086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35524,95,0.88 [0.45-1.72],0.714826664426095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,34646,90,1.08 [0.58-2.02],0.8145675020785645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41529,114,2.90 [1.38-6.10],0.0050031005785566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40836,112,0.89 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40303,112,0.71 [0.39-1.29],0.2630497086917706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,34646,90,0.67 [0.37-1.21],0.1857889309055976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41140,112,1.14 [0.79-1.64],0.4875740237477677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,35680,94,0.90 [0.48-1.70],0.7419687395495891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,34734,94,1.77 [0.78-4.05],0.1723939773237189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,35675,94,0.95 [0.58-1.58],0.8565043928683471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,40101,112,0.53 [0.24-1.17],0.115728461663446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,34912,91,0.94 [0.71-1.26],0.6946453542379575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,40657,108,1.06 [0.63-1.77],0.8286055059640798
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,34912,91,0.81 [0.47-1.40],0.4490723214229036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35524,95,0.67 [0.46-0.99],0.0427305277935085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41192,113,1.13 [1.07-1.19],4.563786141385131e-06
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41331,113,1.36 [0.77-2.40],0.2854796624296117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,35675,94,0.48 [0.24-0.96],0.0383760335858936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,40836,112,1.11 [0.99-1.26],0.084606040278178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,34583,90,1.09 [0.84-1.42],0.5086702380761786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,34912,91,1.04 [0.79-1.37],0.7769101065399663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40303,112,0.98 [0.80-1.20],0.8594519327858241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,35728,94,0.99 [0.74-1.33],0.9395818013083916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,41402,112,1.30 [0.80-2.11],0.2921187652145932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,34553,90,0.74 [0.52-1.06],0.1034272066146203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,34912,91,0.96 [0.76-1.23],0.7565566174528844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFM,Afamin,35728,94,1.13 [0.41-3.14],0.8135715108089004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,40597,108,1.09 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,34583,90,1.06 [0.84-1.33],0.6348064454699676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,40919,112,0.79 [0.55-1.13],0.1932832688252495
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,40035,112,1.08 [1.07-1.09],1.1536790362916134e-69
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,41192,113,1.19 [0.74-1.93],0.4694413712050325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,41497,113,0.89 [0.65-1.22],0.4772235742131361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,35700,95,1.29 [0.57-2.93],0.5489721003467884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,34734,94,0.66 [0.34-1.30],0.2314321591981921
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,34734,94,0.64 [0.31-1.33],0.2282253756359825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,35515,96,0.95 [0.71-1.29],0.7529564518475195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,35700,95,1.01 [0.49-2.07],0.981232893510126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,40961,110,1.21 [0.98-1.49],0.0817765135757634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",34722,92,0.85 [0.65-1.11],0.2373879013682955
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,40101,112,0.93 [0.65-1.34],0.7130149535029737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,34734,94,0.92 [0.63-1.34],0.6680150997919585
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40768,112,0.91 [0.77-1.07],0.2592245868080491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",35607,94,0.90 [0.75-1.09],0.2784210031961082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,34912,91,0.54 [0.19-1.51],0.2396133169600692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,40101,112,1.00 [0.80-1.25],0.981777129923899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,34722,92,1.15 [0.85-1.56],0.3616841825809131
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,40303,112,0.93 [0.67-1.29],0.6638398027518786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,34646,90,1.17 [0.90-1.53],0.2399376601334178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,40075,112,0.95 [0.74-1.22],0.6980976438284294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,35624,95,0.95 [0.81-1.11],0.4974816882781989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,39906,111,0.84 [0.63-1.12],0.2402004464135456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41529,114,1.48 [0.64-3.45],0.3609108293851086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,41034,110,1.16 [0.87-1.55],0.3032427050223956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",35515,96,0.91 [0.60-1.37],0.6521265332464241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40920,113,1.01 [0.78-1.29],0.9631414223948384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35624,95,1.07 [0.71-1.60],0.761493818499928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,35024,96,1.01 [0.66-1.56],0.9527039349676092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,34646,90,0.95 [0.81-1.13],0.5826647134857765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",40836,112,0.91 [0.77-1.08],0.2824005006951279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,40296,112,1.07 [0.59-1.94],0.8301694900950608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,41342,111,1.90 [0.89-4.06],0.0996641953905736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,35680,94,0.70 [0.33-1.48],0.3557136072232999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,40075,112,1.16 [0.92-1.47],0.2111446117558117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,34722,92,0.98 [0.66-1.46],0.929632293641978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,40836,112,1.23 [0.59-2.56],0.5727698306617834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,40296,112,1.04 [0.72-1.48],0.850361698197599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,34912,91,1.39 [0.86-2.26],0.1817998132288946
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,35391,96,0.90 [0.59-1.37],0.6096384155942197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,35607,94,1.13 [0.86-1.47],0.3849660038130025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,33410,87,0.98 [0.64-1.51],0.9396329669971576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,40920,111,0.99 [0.60-1.64],0.9695406731307966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,40873,112,0.82 [0.68-0.99],0.0437417119999449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,41402,112,1.12 [0.73-1.72],0.5966837878156215
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,41057,113,0.84 [0.55-1.28],0.4155469077322847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,41047,111,0.77 [0.48-1.23],0.2698865661965332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,41132,113,1.02 [0.64-1.62],0.9277254223039428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,41402,112,1.13 [0.71-1.79],0.6181420375834908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,34553,90,1.01 [0.76-1.33],0.9666148759175436
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,34646,90,0.93 [0.72-1.20],0.55432077724566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,34431,93,0.98 [0.69-1.40],0.9109482318295994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,40101,112,1.07 [0.81-1.41],0.6233313028741286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34734,94,0.99 [0.61-1.60],0.9570119741778098
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,41113,112,1.00 [0.54-1.82],0.9877192117281454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,34708,91,1.13 [0.74-1.73],0.5649762239262063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,40075,112,0.88 [0.86-0.91],1.6045810730986081e-15
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,40917,113,1.04 [0.81-1.35],0.7497294479435195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,34219,93,0.81 [0.59-1.09],0.1672073198737624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,41321,112,0.97 [0.77-1.23],0.8188846969522326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,40831,110,0.94 [0.74-1.18],0.5812215166750809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,39952,112,0.91 [0.52-1.60],0.7528485847159552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],40296,112,1.01 [0.75-1.35],0.9731457134376864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,41179,112,1.16 [0.70-1.92],0.5744868962198126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,35515,96,0.91 [0.71-1.17],0.4460629111460338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,34722,92,0.74 [0.47-1.17],0.1964653827150442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,35524,95,0.94 [0.72-1.21],0.623123356909376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,35607,94,0.99 [0.65-1.51],0.968899834083723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40836,112,0.85 [0.58-1.26],0.4260315737207577
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,35401,92,1.00 [0.56-1.78],0.9941721976984382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41277,111,1.00 [0.76-1.32],0.9949882372047184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,41028,112,1.43 [0.91-2.24],0.120527888150964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,35728,94,1.25 [0.64-2.42],0.5110422674473205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,35700,95,0.93 [0.62-1.39],0.7087508690741222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,35728,94,1.21 [0.73-2.03],0.4596165672960612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,35700,95,0.73 [0.32-1.67],0.4540668624700568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,34734,94,0.78 [0.50-1.23],0.2887549080112898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,35659,94,0.71 [0.40-1.26],0.2457533148188367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,34101,86,0.67 [0.36-1.24],0.2036683623346953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,35728,94,0.74 [0.52-1.07],0.1096801602822585
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,35700,95,1.22 [0.46-3.20],0.6914506904754831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,41034,110,1.24 [0.79-1.94],0.3560417313046015
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,35700,95,1.07 [0.78-1.46],0.6858965165609973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41120,112,0.97 [0.52-1.79],0.913332393642616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,40976,110,0.89 [0.69-1.15],0.369382949999675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,34912,91,0.94 [0.79-1.13],0.5076326808733953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,40666,108,1.05 [1.05-1.05],0.0
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,35024,96,0.91 [0.68-1.24],0.5591542130278757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,40836,112,0.96 [0.65-1.42],0.8392301745154105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,35524,95,0.91 [0.76-1.08],0.2833888159058537
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,35624,95,0.91 [0.68-1.22],0.523624777564166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",35515,96,0.60 [0.34-1.04],0.0695952944016374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,40101,112,1.02 [0.71-1.47],0.9072546430909768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,40101,112,0.82 [0.61-1.11],0.2085095652912191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,35024,96,0.84 [0.49-1.44],0.5177385886188759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,34912,91,0.93 [0.72-1.19],0.5525135628680788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,34431,93,0.83 [0.62-1.12],0.2231452620377793
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,35607,94,0.89 [0.72-1.11],0.3123087041758869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,35624,95,0.99 [0.80-1.23],0.9487114201434655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,40984,113,0.93 [0.83-1.06],0.27757287746562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,34583,90,0.84 [0.63-1.14],0.2707549026254585
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,34583,90,1.01 [0.61-1.67],0.9762498804615254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,40075,112,1.03 [0.70-1.52],0.8876210229358426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,34553,90,0.85 [0.62-1.16],0.3041355388619299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,34553,90,0.95 [0.58-1.58],0.8547590353699627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,34583,90,0.86 [0.60-1.25],0.4378674450392252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,40296,112,0.99 [0.64-1.53],0.9520821435388096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,34553,90,0.75 [0.47-1.22],0.2486050384370147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,41034,110,0.90 [0.61-1.32],0.578312322989639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,40836,112,0.75 [0.55-1.03],0.0724689786111677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,41179,112,1.17 [0.66-2.09],0.584340126731778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,34583,90,0.88 [0.61-1.26],0.4761696469572715
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,40296,112,1.08 [0.76-1.54],0.658022358598821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,35356,94,1.08 [0.71-1.62],0.7291800007136882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,40726,108,1.24 [0.88-1.75],0.2172468562332469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,35700,95,1.74 [0.84-3.59],0.1363882613497635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,35675,94,1.08 [0.54-2.18],0.824170301015136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,35624,95,0.92 [0.68-1.23],0.5515999825993396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,34734,94,0.94 [0.77-1.14],0.5433609077473699
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,34553,90,0.93 [0.71-1.21],0.590602132879423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,40075,112,1.04 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,34431,93,0.89 [0.48-1.63],0.7009027080638108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,35524,95,0.91 [0.72-1.15],0.4420538259347921
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,40101,112,1.09 [0.82-1.44],0.5464588078776055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,41140,112,0.99 [0.79-1.25],0.9604732495375492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34553,90,0.89 [0.56-1.42],0.6357095581208991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,34553,90,0.95 [0.50-1.82],0.8878903131210034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,34553,90,1.00 [0.60-1.67],0.9906499972308336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,34431,93,1.11 [0.71-1.75],0.6454385840345682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,34553,90,0.86 [0.60-1.23],0.4188800645379027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",34553,90,0.95 [0.63-1.42],0.7959738035087488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",41192,113,0.92 [0.81-1.04],0.1631021929629305
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",40075,112,1.14 [0.78-1.65],0.505802348795537
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,40101,112,1.26 [0.89-1.79],0.1831967668460544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,40836,112,1.29 [0.72-2.28],0.3903477867738956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,39999,112,1.02 [0.79-1.31],0.8898252646972199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,34734,94,1.00 [0.76-1.32],0.9735061867048828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,34553,90,0.84 [0.68-1.05],0.1242368447205854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,35524,95,0.85 [0.41-1.76],0.6636423151106134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",35728,94,0.85 [0.26-2.77],0.7853992957597924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,40075,112,0.94 [0.74-1.18],0.5714912527843203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,34583,90,0.85 [0.68-1.06],0.1460034255531374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,35624,95,0.69 [0.43-1.10],0.1200270441929673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,35607,94,1.00 [0.73-1.36],0.9819042648675952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,40984,113,0.94 [0.78-1.12],0.4675986113511783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,41179,112,1.41 [0.78-2.57],0.2563105825597269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,35624,95,0.97 [0.68-1.39],0.8689939038840352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,35728,94,1.14 [0.67-1.94],0.630456327431197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,34553,90,1.20 [0.47-3.04],0.7055958993753648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34734,94,1.18 [0.68-2.03],0.5559087103914031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41192,113,1.49 [0.82-2.69],0.1881156879934484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",41034,110,0.91 [0.46-1.81],0.7865591908565218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,34646,90,0.91 [0.44-1.84],0.7831754491463073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,40984,113,0.90 [0.72-1.14],0.3819805953932277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,40657,108,0.91 [0.60-1.38],0.6488003695494682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,34646,90,0.91 [0.60-1.39],0.6778376133495945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,40303,112,0.80 [0.50-1.28],0.355396129512655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40101,112,0.81 [0.61-1.06],0.123774681662867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,40101,112,1.17 [0.67-2.05],0.5718025063713383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,40984,113,0.95 [0.79-1.15],0.6065110616476859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,35607,94,0.99 [0.75-1.32],0.9561112646332972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,34722,92,0.87 [0.66-1.15],0.3294586418687016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,40015,112,0.82 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41034,110,0.84 [0.41-1.71],0.6265470617885661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,40726,108,1.04 [0.99-1.10],0.1512644715088136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",35675,94,0.52 [0.26-1.06],0.0732712631491283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34583,90,0.68 [0.42-1.09],0.1114359634809451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,35031,93,1.20 [0.58-2.48],0.6210623071915669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,35524,95,0.64 [0.40-1.02],0.0594488480625476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,35607,94,0.92 [0.76-1.12],0.4254916991160832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40984,113,0.70 [0.50-0.99],0.0433705415120288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,34646,90,1.24 [0.92-1.66],0.1511264077734054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,34431,93,0.78 [0.55-1.12],0.1842843334596761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,35515,96,0.95 [0.62-1.45],0.8138155946492167
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,40984,113,0.89 [0.74-1.07],0.2180499832562829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,35680,94,0.81 [0.65-1.02],0.0696721108891004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,34734,94,0.91 [0.65-1.28],0.5932664259442635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,34431,93,1.00 [0.65-1.53],0.9979483119509684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,35680,94,0.84 [0.67-1.05],0.1341534832886578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,40034,110,1.02 [0.88-1.17],0.807448755513611
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,34583,90,0.89 [0.66-1.22],0.4795910810840066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,34553,90,1.37 [0.64-2.97],0.4198995274737063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,40984,113,1.00 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,41034,110,1.02 [0.85-1.23],0.7959839890202761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,40101,112,0.88 [0.68-1.16],0.3678339786755763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,41529,114,0.84 [0.50-1.42],0.5193080961002798
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,34646,90,0.89 [0.50-1.56],0.6781005447650286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,34583,90,1.22 [0.98-1.51],0.0709872516707248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,35607,94,0.80 [0.48-1.34],0.3967060530348828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,41034,110,1.18 [0.93-1.50],0.1738592791390002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,34912,91,1.00 [0.49-2.03],0.9975181705499516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,40657,108,1.26 [0.88-1.78],0.2030059591212031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,40237,112,0.70 [0.48-1.02],0.0656035975320805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,34912,91,0.64 [0.25-1.60],0.3393619685273308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,35675,94,0.79 [0.44-1.45],0.4505984052035765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34646,90,1.03 [0.65-1.63],0.902944367056452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,40303,112,0.50 [0.24-1.04],0.0632004563823692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,34583,90,0.78 [0.52-1.17],0.220484289470107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,34734,94,1.09 [0.76-1.56],0.6550318517575202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,33510,90,1.01 [0.84-1.22],0.9093547420827656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,40942,111,1.01 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,35612,93,1.06 [0.78-1.44],0.7217689723636687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,35192,95,0.96 [0.81-1.15],0.6754601979170114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,35024,96,1.02 [0.54-1.91],0.9558393049587502
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,34583,90,1.45 [0.95-2.22],0.086056481615691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,34553,90,1.11 [0.77-1.61],0.5610304697427906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,34553,90,0.67 [0.38-1.18],0.1677090001281118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,40075,112,0.87 [0.59-1.27],0.4642519512188261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,34583,90,1.07 [0.68-1.69],0.7762927070069311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,35624,95,0.55 [0.31-0.99],0.0461538572868972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BSG,Basigin,41424,113,1.00 [0.54-1.84],0.9907239945847438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BSND,Barttin,34431,93,1.02 [0.57-1.83],0.9469496828543262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41391,112,1.54 [0.97-2.45],0.070253697758543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41391,112,0.87 [0.62-1.20],0.3908370054471748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,40101,112,0.86 [0.68-1.10],0.2347357816672453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,35728,94,0.99 [0.39-2.55],0.9900200383557468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,34431,93,0.84 [0.63-1.11],0.2204569541444465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,35446,95,1.34 [0.97-1.87],0.0799236169999218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,40984,113,0.70 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,34431,93,0.97 [0.58-1.60],0.8937692407540065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,40075,112,0.86 [0.76-0.97],0.0156619368142649
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,34553,90,1.34 [0.76-2.37],0.3110696527258058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,41288,112,1.44 [0.69-2.98],0.3297781900513312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",35624,95,0.82 [0.58-1.18],0.2891267851389805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,34646,90,1.28 [0.83-1.96],0.264082353473677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41179,112,1.27 [0.87-1.84],0.2139590785193696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,34912,91,1.34 [0.77-2.33],0.2964014469298832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35624,95,0.88 [0.46-1.67],0.6976933374117438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,34846,91,0.99 [0.65-1.50],0.962317932314805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,35728,94,0.85 [0.28-2.58],0.7794088707907456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,35661,94,1.83 [0.64-5.20],0.2569547664986463
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,35728,94,0.80 [0.31-2.05],0.6399871445607274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2,Complement C2,41120,112,0.76 [0.43-1.36],0.3573182379252114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,39999,112,1.15 [0.80-1.66],0.4512326487416145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,34722,92,0.74 [0.49-1.12],0.1577267799820212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C3,Complement C3,33907,85,0.88 [0.54-1.44],0.6078954427602867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,41140,112,1.15 [0.77-1.74],0.4947481440005206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C5,Complement C5,35728,94,1.53 [0.46-5.12],0.4934093545847937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,34870,90,1.06 [0.56-2.03],0.8481456824810003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,35607,94,1.02 [0.44-2.35],0.9692658529504146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,35728,94,0.79 [0.41-1.49],0.4605012230578439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,35700,95,1.22 [0.83-1.79],0.3190265114999977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,35524,95,1.15 [0.91-1.45],0.2426513094407445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,40134,109,1.38 [1.05-1.80],0.0202143632192253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,40101,112,0.77 [0.41-1.44],0.4106002126365814
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,40836,112,0.97 [0.57-1.64],0.8997225985604703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,40567,111,0.98 [0.83-1.15],0.7624681065805576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,41402,112,0.87 [0.53-1.43],0.5829783235067162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,40900,110,1.23 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,41465,114,1.24 [0.96-1.61],0.0958705436907756
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,41529,114,0.91 [0.45-1.84],0.7948718358808088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",40303,112,0.92 [0.77-1.10],0.3418443834083594
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,40904,110,1.03 [0.79-1.34],0.8295230228846489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,35024,96,1.57 [1.05-2.33],0.0274729697031794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,34646,90,1.11 [0.55-2.25],0.7674090419031893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,41402,112,1.03 [0.71-1.49],0.8755424830011374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,34722,92,0.83 [0.60-1.16],0.2705692629901058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,34583,90,0.83 [0.43-1.62],0.5927832134152429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,34553,90,1.19 [0.90-1.56],0.2156104212719262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,34583,90,0.69 [0.46-1.03],0.0672293186205158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,35624,95,0.87 [0.69-1.10],0.244427975416799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,34842,91,0.95 [0.78-1.15],0.6011731060737984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,34722,92,1.03 [0.65-1.64],0.8909427661166582
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,40836,112,1.82 [1.24-2.68],0.002099427047992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,40075,112,0.72 [0.41-1.25],0.239616790342901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,40650,108,1.16 [0.75-1.79],0.4976416082544477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,35607,94,0.67 [0.38-1.20],0.1829958885548932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41275,112,1.03 [0.88-1.21],0.6968622901726895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34734,94,0.91 [0.70-1.18],0.4808441535310473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,34553,90,0.93 [0.53-1.63],0.8100642348904162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,40101,112,0.65 [0.44-0.96],0.0304824986145033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,34722,92,0.64 [0.41-0.99],0.0457050578655561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,35624,95,0.96 [0.80-1.16],0.6824337628599597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,40760,109,1.04 [0.74-1.47],0.8286139390843245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,35515,96,1.19 [0.75-1.89],0.4639632480471829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,35607,94,0.86 [0.66-1.12],0.2738751972732528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,40075,112,1.06 [0.75-1.50],0.721567431838852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,34722,92,0.78 [0.47-1.30],0.3464536670082946
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,40075,112,1.03 [0.79-1.33],0.8355258072402898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,40075,112,0.85 [0.68-1.07],0.173777668105838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,40984,113,0.86 [0.67-1.10],0.2240046147241918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,41529,114,0.96 [0.79-1.15],0.6332818401986275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,35024,96,0.96 [0.85-1.08],0.5113856330036459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,35607,94,0.91 [0.72-1.15],0.4167292706062824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,41280,111,0.97 [0.74-1.27],0.8031795261309118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,34646,90,0.90 [0.65-1.26],0.5486196374529047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,34553,90,0.87 [0.55-1.38],0.5542725159556576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAT,Catalase,35166,95,1.33 [0.95-1.86],0.0992246714655407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,34583,90,1.02 [0.83-1.25],0.8478021578975434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,41402,112,1.30 [0.79-2.13],0.2977936787322286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,34734,94,0.79 [0.51-1.22],0.2806102408917126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,34553,90,0.92 [0.54-1.58],0.7717156975785298
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40726,108,0.99 [0.78-1.25],0.9219419948860182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,35607,94,1.26 [0.97-1.63],0.0821486751734295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,35515,96,0.85 [0.56-1.28],0.4350241272155348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,34722,92,0.75 [0.38-1.48],0.4030025679618865
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,35624,95,0.96 [0.74-1.25],0.7441340301492354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,34734,94,1.05 [0.76-1.45],0.7645503849296171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,41497,113,0.98 [0.63-1.52],0.9250037585981932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,41430,113,0.98 [0.77-1.24],0.8347640830595277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,40920,111,0.82 [0.53-1.27],0.3647111909940129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,41529,114,1.15 [0.80-1.66],0.457447657260262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,41529,114,1.27 [1.12-1.44],0.000180450820925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,40939,113,0.91 [0.76-1.10],0.3292688857503201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,40457,111,0.95 [0.75-1.20],0.6799871413349903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,41391,112,0.98 [0.85-1.12],0.7288355177226253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,40657,108,1.08 [0.79-1.48],0.6318734875323119
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,41497,113,0.91 [0.75-1.11],0.3534314285198995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,41192,113,0.93 [0.61-1.41],0.7297717978387328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,40587,111,0.87 [0.64-1.18],0.3743588102853781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,41192,113,0.83 [0.60-1.14],0.2568972504718984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,41132,113,1.09 [0.89-1.32],0.4071153869342707
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,41497,113,1.08 [0.77-1.51],0.6490173021843907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,40984,113,0.91 [0.74-1.10],0.3280006413450773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,41028,112,1.16 [0.86-1.56],0.3260380169725176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,40846,113,0.99 [0.74-1.32],0.9505890881666428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,40984,113,0.88 [0.58-1.32],0.5257492999583135
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,41066,113,0.96 [0.74-1.23],0.7390624526083047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,41179,112,0.91 [0.77-1.07],0.2501850313001967
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,40984,113,1.01 [0.76-1.35],0.9280600404126784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,41342,111,1.06 [0.81-1.38],0.6794815343386282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,40768,110,0.89 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,41006,113,0.72 [0.53-0.98],0.0371816478555857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,41459,114,1.29 [0.74-2.24],0.3753687293374576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,41402,112,0.93 [0.70-1.23],0.625803527930302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,41034,110,1.18 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,35024,96,0.95 [0.57-1.61],0.8561476908013271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,34646,90,0.90 [0.70-1.15],0.4044543290697574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,40726,108,1.14 [0.80-1.62],0.4613294470673207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,40101,112,0.83 [0.56-1.24],0.3736849409511805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,35524,95,0.84 [0.54-1.29],0.4266472947150729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,41034,110,0.60 [0.37-0.98],0.0432712807322295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40190,109,0.99 [0.65-1.51],0.979745596255442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,41497,113,1.17 [0.82-1.65],0.3901391141287648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,41034,110,0.98 [0.53-1.83],0.952264754477441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,34722,92,0.92 [0.52-1.61],0.7614878136442006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,40973,110,1.09 [0.95-1.25],0.2384290301389779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,41140,112,1.10 [0.54-2.23],0.7987371432641813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,34553,90,1.13 [0.71-1.80],0.6093016921810326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,40984,113,1.21 [0.64-2.30],0.5605664484425514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,40850,113,1.28 [0.80-2.05],0.2959920434001365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,40104,111,1.63 [1.06-2.50],0.0245935003247024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,41124,113,0.95 [0.62-1.47],0.8328972285641493
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41497,113,1.07 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,34646,90,1.00 [0.62-1.63],0.9892908900722364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,41497,113,0.90 [0.49-1.68],0.7439227002385476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,35680,94,0.87 [0.53-1.43],0.5856260234468467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41140,112,1.03 [0.71-1.50],0.8702531633830289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,40726,108,0.92 [0.57-1.49],0.7329974247194424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,40992,112,0.96 [0.60-1.54],0.8705808881053116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40101,112,1.07 [0.68-1.67],0.7740467293812716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,34912,91,1.08 [0.55-2.12],0.8251515230134101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41391,112,0.93 [0.59-1.46],0.7460060524394201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,41269,112,1.19 [0.82-1.73],0.3634156490864965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,41402,112,1.03 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,41034,110,1.04 [0.66-1.64],0.8727298303843936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,40836,112,1.64 [1.03-2.62],0.0387298966840672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,41140,112,1.23 [0.99-1.54],0.062669817543635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,41249,112,0.91 [0.45-1.83],0.7924102238905643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,34646,90,0.87 [0.54-1.39],0.5497578702147712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40836,112,1.28 [0.78-2.11],0.3308440848073835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,34583,90,1.07 [0.60-1.90],0.8214515541966038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,35024,96,1.03 [0.61-1.75],0.909428294600444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,34646,90,1.04 [0.84-1.28],0.7221558607466009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,40910,113,0.60 [0.32-1.13],0.114569512518376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,41006,113,0.86 [0.78-0.94],0.0011019244987648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,41497,113,0.89 [0.72-1.09],0.2609794532348842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,40785,111,0.86 [0.47-1.57],0.6245103040494391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41132,113,0.97 [0.55-1.70],0.914456680507041
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,41342,111,0.98 [0.59-1.64],0.944944997121168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,39601,111,1.24 [0.73-2.11],0.4190665046765698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,40924,112,1.14 [0.43-3.01],0.7906134315747976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,39552,108,1.67 [1.38-2.02],1.814116061934809e-07
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35541,92,0.75 [0.48-1.15],0.1888628900220009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,41424,113,1.05 [0.77-1.45],0.7477786505200379
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,40657,108,0.92 [0.66-1.29],0.6419021840674481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,34580,90,1.01 [0.63-1.62],0.9624734433465272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,40984,113,0.69 [0.46-1.02],0.0658405082439306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,34912,91,1.09 [0.67-1.78],0.7364831964266695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41391,112,1.14 [0.73-1.79],0.5572633987994718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41497,113,1.23 [0.84-1.78],0.2824884851258071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35675,94,1.20 [0.66-2.17],0.5500748020223026
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,35024,96,1.25 [0.85-1.83],0.2658356121133759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,40984,113,1.10 [0.37-3.24],0.8611568191669925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,40984,113,0.56 [0.33-0.94],0.0283412039222266
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35524,95,0.98 [0.50-1.93],0.9560159397869036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,41391,112,1.13 [0.81-1.58],0.4591657178478128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,39474,109,0.93 [0.53-1.62],0.7899406074152578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,41034,110,1.39 [0.57-3.38],0.4622353878111632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,41034,110,0.90 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,35613,94,1.43 [0.99-2.05],0.05450364869002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,35607,94,2.01 [1.27-3.19],0.0030032092188748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,34431,93,1.08 [0.81-1.43],0.6149186363469746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,34431,93,1.00 [0.61-1.64],0.99146639201178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,35458,95,0.97 [0.73-1.28],0.8249735285502076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,40101,112,0.81 [0.60-1.10],0.1823531909670765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,41140,112,0.94 [0.77-1.14],0.5177149595349058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,35524,95,0.91 [0.75-1.10],0.3292168357370213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40726,108,0.87 [0.58-1.31],0.5026706713924971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,39647,109,0.95 [0.61-1.49],0.8276304383834052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,41315,112,0.90 [0.67-1.21],0.487158202534781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,35024,96,1.23 [0.66-2.29],0.5144181331082955
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,35607,94,1.55 [0.81-2.98],0.185534303244895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,41391,112,1.21 [0.76-1.92],0.4256198861054735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,34583,90,1.21 [0.83-1.76],0.3218784023725207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,41529,114,1.19 [0.69-2.06],0.5274373210749224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,40075,112,0.91 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,40836,112,0.86 [0.68-1.09],0.221071538485737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,34431,93,0.95 [0.55-1.63],0.8445687854660089
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,35624,95,1.00 [0.71-1.39],0.985901036328514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,34583,90,0.91 [0.60-1.36],0.6393317317921814
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,40836,112,0.91 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40836,112,0.99 [0.83-1.19],0.9376161575030412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,40836,112,1.29 [0.95-1.75],0.0983564396458256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41065,113,0.77 [0.41-1.45],0.4158199132892275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,41366,113,1.42 [1.19-1.71],0.0001228255040836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41074,111,1.00 [0.43-2.33],0.9966525202755512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35524,95,1.43 [1.11-1.84],0.0051795929275444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,35024,96,0.86 [0.61-1.20],0.3646021358443836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,35524,95,0.74 [0.45-1.22],0.2376252305826204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,35024,96,1.14 [0.76-1.72],0.5198810291499067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40984,113,0.79 [0.64-0.98],0.0314337488153418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,40101,112,0.98 [0.68-1.39],0.8923292904413083
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39563,111,0.82 [0.62-1.09],0.1736209299702474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,35680,94,0.77 [0.45-1.31],0.3397572446137684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40303,112,1.05 [0.74-1.48],0.7891730264994707
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,34646,90,1.04 [0.63-1.72],0.8823846612319316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,40303,112,0.94 [0.60-1.47],0.7717517364346084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,35680,94,0.86 [0.62-1.19],0.3473248020118629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,41460,114,0.92 [0.69-1.23],0.5760806609483997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,34912,91,0.66 [0.32-1.37],0.2673342948271374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,34646,90,1.14 [0.65-1.98],0.6482588481315052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,34583,90,0.88 [0.60-1.30],0.5292550547260095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,35024,96,1.19 [0.86-1.66],0.2999127115969875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,35024,96,1.09 [0.85-1.41],0.4864118272116092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,34553,90,1.21 [0.84-1.75],0.2987950996983862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,34431,93,1.13 [0.73-1.75],0.5986266413583157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,40296,112,0.89 [0.66-1.20],0.4440482628496147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,34734,94,0.93 [0.71-1.22],0.6025033445077457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,40101,112,1.04 [0.83-1.29],0.7565218616988777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,35024,96,1.08 [0.77-1.53],0.6444452622064225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,34431,93,1.11 [0.66-1.86],0.6903152291889062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,39987,112,1.03 [0.80-1.31],0.8382540527877897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,40101,112,0.91 [0.69-1.19],0.4866549157966207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,40075,112,0.89 [0.67-1.18],0.4193636461023647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,41118,113,1.09 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,40836,112,0.94 [0.63-1.41],0.7721438678663184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,40836,112,0.99 [0.77-1.26],0.9132979943414268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,40075,112,0.89 [0.69-1.16],0.3952768870590241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,35524,95,0.82 [0.63-1.06],0.133264196088842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,35079,90,1.02 [0.55-1.89],0.960372598876664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,40101,112,0.91 [0.62-1.32],0.6140637735932137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,35728,94,1.64 [0.66-4.04],0.2849460797415071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,33659,86,1.29 [0.53-3.17],0.573862058003799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,35470,92,0.98 [0.69-1.38],0.906594743867682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,35663,94,0.86 [0.66-1.12],0.2636468672967194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,35236,95,0.92 [0.58-1.48],0.7441340406771124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,35728,94,1.03 [0.38-2.79],0.945945284341678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFP,Properdin,35728,94,0.84 [0.34-2.12],0.7186917430524071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,41034,110,1.01 [0.81-1.25],0.9317233854863656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,35700,95,1.40 [1.11-1.76],0.0043217542290579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,34722,92,1.13 [0.72-1.79],0.5855006843093895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,40101,112,0.90 [0.67-1.20],0.4643366837671359
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,34912,91,0.70 [0.48-1.02],0.0630709633256728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35607,94,1.13 [0.70-1.83],0.6232689949102257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,35515,96,0.77 [0.36-1.64],0.49914638726415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,40303,112,1.14 [0.70-1.85],0.6091235813637942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,35680,94,1.05 [0.84-1.32],0.6404987837965435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,41249,111,1.02 [0.67-1.55],0.9376648026786386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,41206,112,0.92 [0.84-1.01],0.0816688652928389
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,41115,112,0.76 [0.43-1.34],0.3415548257841174
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,34722,92,0.80 [0.57-1.13],0.2096788384951258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,40726,108,0.95 [0.76-1.18],0.626527116047309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,35675,94,0.83 [0.58-1.18],0.3054463500938305
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,34583,90,0.84 [0.62-1.14],0.2700109863481769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,41132,113,0.89 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,34722,92,0.98 [0.56-1.71],0.9491588138657356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,41140,112,1.00 [0.76-1.30],0.9789686662766204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,35680,94,0.74 [0.53-1.04],0.0868137288312815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,35024,96,1.56 [1.17-2.09],0.0027634082444688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,35524,95,0.91 [0.74-1.12],0.3770418184117643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,34722,92,1.05 [0.69-1.61],0.8104184766277904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41298,113,1.03 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,35680,94,1.00 [0.71-1.41],0.9923528355303388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40865,112,0.82 [0.67-1.00],0.0553975157149108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,34431,93,0.83 [0.62-1.13],0.2374889199921883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,40964,112,0.87 [0.66-1.14],0.3110714139917803
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,40726,108,1.31 [0.82-2.10],0.2575454741899029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,40958,110,1.07 [0.76-1.52],0.6897977490353169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,34646,90,1.49 [0.60-3.70],0.3864649935044577
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,41034,110,0.94 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,40303,112,0.81 [0.48-1.37],0.4386530168300186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,41391,112,0.91 [0.76-1.08],0.2756135254143427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,34722,92,0.77 [0.48-1.22],0.2605019581353965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,34891,88,0.98 [0.38-2.54],0.974896111488652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,40984,113,0.95 [0.60-1.52],0.8350923894484972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,40984,113,0.74 [0.52-1.05],0.091723568241844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,40984,113,0.86 [0.78-0.95],0.0039569319228095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,40984,113,1.54 [0.94-2.55],0.0896127110031937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,35619,94,1.00 [0.66-1.50],0.9930172505140206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,40101,112,1.01 [0.71-1.43],0.9617617681390758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,41497,113,1.17 [0.85-1.61],0.3335861678355046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,34722,92,0.88 [0.55-1.41],0.5915920811454919
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,34722,92,0.87 [0.44-1.72],0.6954358864321077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,34431,93,1.11 [0.76-1.63],0.5792967541436327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,40984,113,0.93 [0.80-1.08],0.3264073482715168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,41402,112,1.85 [0.86-3.98],0.1124470975837881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,34722,92,0.95 [0.52-1.73],0.8593086835418156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40650,108,0.93 [0.74-1.18],0.5648556667719413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,40961,110,1.05 [0.82-1.33],0.713220212881722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,39999,112,0.71 [0.40-1.26],0.2425568455563395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,40075,112,0.98 [0.70-1.37],0.9120800466647052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,41497,113,0.93 [0.60-1.43],0.7288000620186201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35607,94,0.76 [0.39-1.49],0.4278247575564411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,40303,112,0.78 [0.52-1.15],0.2094378240459038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,35728,94,0.83 [0.38-1.79],0.6333828888108106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,35675,94,0.88 [0.70-1.09],0.239691098805497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,35515,96,0.96 [0.76-1.22],0.7563210761417055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,41179,112,1.27 [0.88-1.85],0.1981306763976685
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,34583,90,1.11 [0.80-1.56],0.5221186540712726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",34669,94,0.94 [0.73-1.21],0.6153038353783512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,40303,112,1.01 [0.76-1.33],0.968908708662076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,40836,112,0.91 [0.73-1.13],0.391260193959064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,34583,90,1.34 [0.77-2.35],0.3037476275407421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,41529,114,1.06 [0.57-1.95],0.860148806379802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,41402,112,1.00 [0.69-1.44],0.980029907016338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,41034,110,1.01 [0.53-1.92],0.98114348341832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,41034,110,1.31 [0.65-2.62],0.4466172634127457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,41127,111,0.96 [0.60-1.52],0.8498236146685804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,40984,113,0.87 [0.57-1.32],0.5157849686398528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,34722,92,0.92 [0.74-1.13],0.4310975845912478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,35675,94,0.88 [0.57-1.36],0.5610555445417514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,35680,94,0.84 [0.39-1.81],0.6630808340822457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,41195,111,1.43 [0.68-3.01],0.3462468261108654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,41529,114,0.69 [0.36-1.33],0.2638964152832374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,35524,95,0.91 [0.64-1.29],0.5925152196457286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,34722,92,1.03 [0.78-1.34],0.856148979373734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,34734,94,0.92 [0.71-1.18],0.4878934108851707
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,35680,94,0.95 [0.40-2.22],0.8995110078669222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41028,112,0.76 [0.49-1.17],0.2091202609521041
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,34964,96,1.15 [0.78-1.68],0.4852656071398086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,34912,91,1.00 [0.59-1.68],0.9924991215109475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,41529,114,1.17 [0.71-1.93],0.5487156691073745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,40984,113,0.59 [0.40-0.87],0.0083126924399623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,35024,96,0.76 [0.46-1.24],0.2697253969635578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,40992,112,0.90 [0.58-1.40],0.6413505723232853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,34734,94,0.98 [0.71-1.35],0.8805623266325713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,35515,96,1.01 [0.62-1.64],0.971705816327042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,40590,110,1.18 [0.73-1.93],0.4982687478837638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,39871,112,1.02 [0.84-1.23],0.8439276827877007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',34553,90,0.82 [0.50-1.35],0.4400234794341866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,40075,112,0.81 [0.54-1.23],0.32399853425043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34734,94,0.83 [0.51-1.34],0.4398567827209059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,34583,90,1.19 [0.71-2.00],0.5110933827949966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40836,112,0.79 [0.61-1.02],0.0692261369093132
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,35675,94,0.64 [0.34-1.22],0.1731231299130323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,41529,114,0.93 [0.70-1.22],0.5926610333931845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,41251,111,1.03 [0.80-1.34],0.7949320806412764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,34221,90,1.01 [0.63-1.63],0.964027999611668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,41529,114,0.99 [0.75-1.32],0.9478859026164136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,35659,94,0.47 [0.20-1.11],0.0839031779550411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,41080,112,0.86 [0.57-1.30],0.4685669954423195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,34431,93,0.92 [0.48-1.79],0.8131409708190656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,41197,111,0.83 [0.50-1.38],0.4758572308065563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",34646,90,0.58 [0.26-1.29],0.1823439815177459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,41391,112,0.91 [0.71-1.18],0.4845989940420957
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,35611,94,0.53 [0.32-0.89],0.0165281296934128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,34553,90,0.94 [0.56-1.59],0.8137133277263382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,41339,112,1.11 [0.74-1.68],0.6043355210031207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,41140,112,0.82 [0.64-1.05],0.1103376840031387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,35675,94,1.26 [0.59-2.68],0.5541447986235564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35563,95,1.06 [0.61-1.86],0.8329944186813175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41179,112,1.07 [0.75-1.54],0.7035971058621902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,40101,112,0.97 [0.80-1.19],0.7890113121761809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,40650,108,0.96 [0.76-1.20],0.6937184919874049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,34431,93,0.65 [0.42-1.01],0.0536998515967125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,34431,93,1.12 [0.53-2.36],0.7689345905002627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,34912,91,0.97 [0.56-1.67],0.9086301452387048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,41132,113,0.88 [0.64-1.21],0.4282198835364039
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,40034,112,0.80 [0.66-0.98],0.0300258206327202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,40992,112,1.04 [0.58-1.87],0.8889833186996945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,40303,112,1.02 [0.77-1.34],0.90910112501462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41192,113,0.96 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,40726,108,0.76 [0.48-1.19],0.2326629118288954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,41402,112,1.04 [0.78-1.40],0.769804940202116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,35365,94,1.27 [0.61-2.67],0.5240839079744966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,41064,113,0.94 [0.81-1.10],0.4598938293876824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,41192,113,1.20 [0.62-2.33],0.5838141762164882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,39863,108,1.13 [0.87-1.46],0.3552010477687346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,41529,114,1.14 [0.68-1.89],0.6233594190646863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,40726,108,1.36 [0.98-1.91],0.0691703796402929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,34722,92,0.81 [0.52-1.28],0.3722859507550001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,40303,112,1.06 [0.92-1.23],0.4049172473752163
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,35675,94,0.84 [0.61-1.14],0.2584342686153137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,35607,94,0.62 [0.39-1.00],0.0515169209884836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,35607,94,0.88 [0.72-1.08],0.2291648032248674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,34583,90,0.97 [0.73-1.28],0.8102885793453715
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,34734,94,0.95 [0.76-1.18],0.6443031415743893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,34553,90,0.99 [0.84-1.17],0.9271327479178532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41192,113,1.48 [0.79-2.74],0.218611142895115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35700,95,1.15 [0.70-1.87],0.5839882392513541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,34553,90,1.12 [0.65-1.93],0.6918033730556541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40726,108,0.97 [0.73-1.28],0.8243950398470952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,34646,90,0.99 [0.62-1.58],0.9619786607140872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,40296,112,1.04 [0.73-1.46],0.8387471469207448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,34646,90,0.66 [0.32-1.36],0.2568797388652777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,35700,95,1.19 [0.70-2.02],0.5127911654623428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,34646,90,0.80 [0.56-1.12],0.1932726336075629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,35624,95,1.20 [0.78-1.84],0.4048979943051722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,35680,94,0.95 [0.52-1.74],0.8779660288323556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,34583,90,1.17 [0.81-1.70],0.4018376775465067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,34553,90,1.02 [0.83-1.26],0.8176163215583931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,30963,77,1.11 [0.90-1.39],0.3295367414048932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,41111,112,1.35 [1.35-1.35],0.0
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,40263,106,1.13 [0.77-1.65],0.5434987608855234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,39979,110,1.28 [0.90-1.81],0.1722709372258098
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,41066,113,0.98 [0.82-1.17],0.8294941108544179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,40466,112,1.21 [0.87-1.70],0.2617197740268372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,34954,96,0.86 [0.58-1.30],0.4817614997011175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,35185,95,0.94 [0.45-1.97],0.8750834864236244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,40303,112,0.93 [0.76-1.14],0.506125411492601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,35680,94,0.63 [0.31-1.30],0.2125705329641007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,35680,94,0.74 [0.38-1.46],0.3876301645782692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,34583,90,1.17 [0.70-1.95],0.5417816268721222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,41034,110,0.91 [0.67-1.24],0.5375682110991475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,41002,113,0.90 [0.69-1.16],0.4127639569239212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,35607,94,0.80 [0.60-1.07],0.1330709743168306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,41053,113,0.89 [0.65-1.24],0.4983963560763825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,38325,106,0.97 [0.62-1.52],0.9007045769821527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,34912,91,0.90 [0.61-1.33],0.5983659447159275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,41140,112,1.02 [0.67-1.57],0.9100112990752288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,40179,112,0.84 [0.67-1.05],0.1296864324355027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,41497,113,1.02 [0.55-1.90],0.9436439416407432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,32287,84,0.68 [0.35-1.33],0.2601121259887036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,41274,112,1.26 [0.86-1.85],0.2298585953253679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41042,112,0.94 [0.55-1.61],0.8317165691541812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,34722,92,1.23 [0.77-1.98],0.3838469209939067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,35315,95,1.07 [0.80-1.42],0.6585879967511135
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,40726,108,1.08 [0.65-1.81],0.7663222219329504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,40984,113,0.95 [0.63-1.43],0.810682280525117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,40939,113,1.10 [0.94-1.30],0.2410531070321876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,41192,113,1.13 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,41391,112,0.96 [0.78-1.17],0.6585983005888556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,40296,112,0.81 [0.53-1.25],0.3444882767488106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,41391,112,0.81 [0.59-1.12],0.2096974335724363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,40296,112,1.04 [0.79-1.36],0.7925002174642588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,41459,114,1.40 [0.71-2.76],0.3319938422616161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,41006,113,0.96 [0.81-1.15],0.6702320677442957
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,40893,112,0.96 [0.83-1.11],0.5871718712964213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,41497,113,1.04 [0.94-1.17],0.4390746430495874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,41192,113,1.13 [1.09-1.16],1.3146057127752948e-12
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,34431,93,0.88 [0.65-1.20],0.4236531162818426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,35118,95,0.82 [0.57-1.18],0.289640758899548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",34553,90,1.16 [0.96-1.40],0.1303285922584664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,34431,93,0.92 [0.69-1.22],0.5527182514507922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,35680,94,1.22 [0.54-2.78],0.6283020624764798
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,34912,91,0.90 [0.70-1.15],0.3990950640164701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,41402,112,0.97 [0.84-1.13],0.7277404487707081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,41192,113,0.78 [0.55-1.12],0.175161779246411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,34646,90,1.29 [0.97-1.72],0.0811956852110694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,34646,90,1.11 [0.80-1.55],0.5285652534319845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40984,113,0.99 [0.78-1.25],0.9184196445763128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",40650,108,0.95 [0.75-1.19],0.6354581237181014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,35638,95,0.93 [0.79-1.10],0.4245059465793661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,40847,109,0.96 [0.77-1.19],0.7081168563999478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,34646,90,0.81 [0.53-1.22],0.3101580479126581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,41192,113,0.96 [0.80-1.14],0.6227652150929657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41140,112,1.09 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,34722,92,1.36 [0.68-2.74],0.3827336203529182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,34431,93,0.68 [0.47-0.99],0.0427776882263358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,34431,93,1.11 [0.59-2.07],0.7465628382512759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCN,Decorin,40303,112,0.58 [0.27-1.23],0.1560192923614388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,34912,91,0.92 [0.74-1.14],0.4350263246898892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,41402,112,1.01 [0.78-1.30],0.9599313452475108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,40836,112,1.04 [0.86-1.25],0.702741586196789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,40075,112,0.75 [0.57-0.98],0.0356659887233052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,34583,90,0.96 [0.73-1.26],0.7781931820166288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,34431,93,0.88 [0.67-1.15],0.3472280844644839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,41140,112,1.08 [0.80-1.45],0.6325139390392399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,34553,90,1.03 [0.62-1.69],0.9211051052634966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40836,112,0.88 [0.60-1.31],0.5351123575703907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,35624,95,0.92 [0.69-1.24],0.6025233957047121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,34912,91,1.09 [0.85-1.41],0.5071392406589103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41391,112,1.06 [0.50-2.24],0.8738203805501458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,35680,94,1.11 [0.70-1.77],0.6476377587133144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,35524,95,0.94 [0.63-1.41],0.7693693444885064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,34722,92,0.92 [0.53-1.62],0.7825528667723383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,34646,90,0.57 [0.22-1.51],0.2596627220780878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,34646,90,1.07 [0.76-1.52],0.7036300815276044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,34722,92,0.95 [0.54-1.66],0.8488468186294614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,40101,112,1.01 [0.75-1.34],0.9692559531820786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40984,113,0.90 [0.76-1.07],0.2354295666878525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,40206,111,1.28 [1.20-1.37],2.972721254683728e-13
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,34386,89,0.98 [0.59-1.61],0.9220549612234414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,34583,90,1.19 [0.86-1.64],0.2927887036073042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,34583,90,0.89 [0.66-1.20],0.4477010503195453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,34583,90,0.74 [0.46-1.19],0.2115700454553017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,40435,111,0.95 [0.86-1.04],0.2742713927786767
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,34553,90,0.65 [0.38-1.12],0.1202460098083458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,34646,90,0.90 [0.62-1.31],0.5877865988939738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,41497,113,0.86 [0.67-1.11],0.2584599955819202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,34583,90,1.13 [0.76-1.70],0.5462133390720731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,34646,90,0.99 [0.68-1.45],0.976485614018291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,40296,112,0.92 [0.57-1.48],0.7299104541968826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,34553,90,0.82 [0.52-1.31],0.4144534704947888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,35515,96,1.22 [0.81-1.84],0.3368471340151668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,35607,94,0.96 [0.62-1.47],0.8414596878626507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,34722,92,1.61 [1.16-2.24],0.0044303378942587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,34912,91,0.65 [0.31-1.36],0.2538479838722821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,41391,112,0.86 [0.65-1.14],0.2857645243323167
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,41529,114,1.27 [0.74-2.20],0.3878041734806133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,40662,108,1.02 [0.71-1.48],0.9108606558489426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,40836,112,1.00 [0.83-1.22],0.972038651013775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,35607,94,0.87 [0.65-1.15],0.3309966225096568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,35624,95,0.92 [0.61-1.39],0.6956687862002615
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,41529,114,1.20 [0.89-1.61],0.2273309618921052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41140,112,0.97 [0.56-1.70],0.9270241807051388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,34734,94,1.08 [0.90-1.29],0.4035254280155722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,34734,94,0.74 [0.47-1.16],0.1878075860726276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,34734,94,0.82 [0.61-1.11],0.1937505411881441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,34431,93,0.94 [0.60-1.48],0.7982643149546722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,41371,113,0.93 [0.76-1.13],0.4495410522299569
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,35607,94,1.11 [0.85-1.46],0.4353294167524155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,40836,112,0.95 [0.80-1.13],0.5540168229484843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,35524,95,0.96 [0.71-1.31],0.8055979502320498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,34912,91,1.02 [0.70-1.48],0.9287959577848766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,34578,90,0.94 [0.74-1.20],0.6318773615116309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,40303,112,0.95 [0.70-1.31],0.7699462273057445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,35607,94,0.73 [0.43-1.25],0.2562130003544491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,34734,94,0.90 [0.71-1.14],0.3794028994735157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,35524,95,0.98 [0.76-1.26],0.8493299026661867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,40932,113,1.43 [0.76-2.71],0.269100871885307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,34583,90,0.86 [0.66-1.12],0.2582626718940625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,35524,95,0.90 [0.76-1.07],0.2240111728097588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,35624,95,1.06 [0.74-1.50],0.762283329867014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,40726,108,0.87 [0.65-1.16],0.3310823888888257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,35607,94,0.93 [0.66-1.30],0.6753932704389725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,34722,92,1.28 [0.82-2.00],0.2723211943086505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,34583,90,1.10 [0.95-1.28],0.1926496917413355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,35607,94,0.98 [0.85-1.14],0.816148335505525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,40650,108,1.05 [0.73-1.50],0.7913537995196855
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,40836,112,0.80 [0.45-1.44],0.4580042423308076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,40984,113,0.78 [0.47-1.28],0.3235304402932746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,40263,111,1.18 [0.69-2.03],0.547674031312342
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,40836,112,1.18 [0.85-1.62],0.3188199737647603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,40700,111,0.84 [0.63-1.11],0.212909222068891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,41529,114,1.52 [1.03-2.26],0.0370587806393185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,41277,111,0.92 [0.68-1.24],0.5649482377023789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,40726,108,1.34 [0.81-2.23],0.2506790382825035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,40836,112,0.88 [0.65-1.19],0.4040068062178295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40560,110,1.10 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,35624,95,1.45 [0.84-2.51],0.1783320529488309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,41034,110,1.78 [0.95-3.33],0.0697410566202311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,41274,111,1.39 [0.85-2.29],0.1904074496242063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,40691,112,0.92 [0.65-1.29],0.6324440782376013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,34912,91,0.90 [0.71-1.14],0.3854457382249662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,35449,96,1.13 [0.73-1.76],0.5788826690758423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,34722,92,0.91 [0.65-1.28],0.5937940539855846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,40836,112,1.58 [1.15-2.18],0.0049629696092282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,35675,94,0.92 [0.69-1.23],0.5831891726058598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,40303,112,1.02 [0.81-1.28],0.8683876334536411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,35515,96,1.20 [0.77-1.86],0.4244914733591313
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,34722,92,1.02 [0.76-1.38],0.8772834914717106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,40075,112,0.88 [0.71-1.09],0.2406739814604904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",35524,95,0.89 [0.73-1.08],0.2277817033158669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,35607,94,0.80 [0.51-1.25],0.3249989809120929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,35515,96,1.12 [0.77-1.62],0.5459471877929201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,34722,92,0.86 [0.65-1.12],0.2590949676974425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,35515,96,0.82 [0.52-1.30],0.4047868169550466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40726,108,0.89 [0.75-1.07],0.223794868511171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41340,112,1.14 [0.66-1.99],0.6345592524634552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,40075,112,0.90 [0.56-1.47],0.6815139044096035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35675,94,0.85 [0.64-1.14],0.2821738340219276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",34734,94,0.84 [0.68-1.04],0.11424058254719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,34553,90,1.10 [0.80-1.51],0.5483994975403403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,34739,88,1.23 [0.69-2.20],0.4769006951493736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,34583,90,1.10 [0.78-1.56],0.5813243460743106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41402,112,1.00 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,40984,113,0.85 [0.73-0.99],0.0327082596269144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,35515,96,1.26 [0.88-1.79],0.2057511562543245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34553,90,0.74 [0.40-1.39],0.3564305597905152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,35624,95,0.96 [0.72-1.28],0.794497239900809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40303,112,0.59 [0.43-0.81],0.0010272936958318
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,34734,94,0.76 [0.38-1.52],0.4322539561199591
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,34646,90,0.57 [0.32-1.04],0.0677834967389569
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,35675,94,0.99 [0.80-1.23],0.9275897278136648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,35524,95,1.20 [0.61-2.37],0.597795494882178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,35024,96,0.74 [0.41-1.33],0.3133741386006081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41110,112,1.34 [0.77-2.34],0.3012481693127665
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,35624,95,1.03 [0.59-1.81],0.9184786243420066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,40968,109,0.96 [0.49-1.86],0.9002540300621136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40657,108,0.99 [0.55-1.76],0.96214133276385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,34722,92,1.27 [0.97-1.65],0.0803039580992917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,40942,112,0.91 [0.78-1.07],0.2657200030888182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,40101,112,0.88 [0.56-1.40],0.6033270454932995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,35524,95,0.59 [0.30-1.17],0.1306575294852781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,41529,114,1.89 [0.69-5.18],0.2186229869569365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,40984,113,0.82 [0.59-1.14],0.2303146077493063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,35675,94,0.90 [0.69-1.18],0.465115944398771
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,34734,94,0.90 [0.77-1.07],0.2395799005752981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",35607,94,0.75 [0.49-1.14],0.1739866154892889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",35400,95,0.92 [0.77-1.11],0.4043321252545093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,34553,90,0.89 [0.64-1.23],0.4666248357252559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,34734,94,0.90 [0.56-1.46],0.6774256790392259
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,40726,108,0.94 [0.70-1.27],0.7063456224526966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,34646,90,0.98 [0.78-1.23],0.8628362384448468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41497,113,0.96 [0.81-1.14],0.6083140794009165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,35624,95,0.72 [0.52-0.99],0.0451465197421717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,34553,90,1.23 [0.82-1.85],0.3213994848835503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,40296,112,1.08 [0.63-1.87],0.7703646861663875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,35624,95,0.98 [0.78-1.23],0.8483022706790351
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,34583,90,0.87 [0.67-1.13],0.2897805074330185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELN,Elastin,35675,94,1.16 [0.66-2.06],0.5998242396777018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,40836,112,1.03 [0.77-1.39],0.8304497221726851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,34553,90,0.57 [0.30-1.06],0.0739591682180446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,40296,112,0.77 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,32939,92,1.30 [0.90-1.88],0.1650475971008592
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41529,114,0.75 [0.28-1.96],0.551694810737164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,40978,111,0.93 [0.76-1.15],0.5296279210597813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,41391,112,0.92 [0.85-1.00],0.0450259610016326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,34734,94,0.78 [0.54-1.13],0.188100352379944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,35515,96,1.14 [0.87-1.51],0.3451593044450469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34553,90,1.28 [0.64-2.54],0.4867402198169853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,34553,90,1.09 [0.72-1.66],0.6706191139711593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41529,114,1.38 [0.77-2.49],0.2803712096460736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41192,113,1.12 [0.88-1.43],0.368208515767127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,34734,94,1.04 [0.61-1.80],0.8802377512013895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,35515,96,0.75 [0.50-1.12],0.1583259825912419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40101,112,0.84 [0.57-1.24],0.381366557397684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40303,112,0.64 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40303,112,0.70 [0.40-1.20],0.1942503276608165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,34734,94,0.87 [0.61-1.25],0.4568851389144996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,34646,90,1.06 [0.56-2.02],0.8477188287717603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,34722,92,1.15 [0.88-1.52],0.3110731325018507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,40992,113,1.09 [0.92-1.28],0.3257073593149406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,35515,96,0.86 [0.53-1.39],0.5443784083893497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,40075,112,0.92 [0.69-1.21],0.5483617720297155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39579,108,1.20 [0.69-2.09],0.5215476995470248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,34912,91,0.63 [0.31-1.29],0.208361245422187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,41529,114,1.70 [1.39-2.08],2.606370096812357e-07
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,40650,108,1.04 [0.60-1.81],0.8827378312479031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,40303,112,0.75 [0.54-1.03],0.0755392129016366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,35024,96,1.30 [0.91-1.87],0.1534322734301224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,40984,113,1.09 [0.87-1.35],0.4635619115094257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,34734,94,0.87 [0.65-1.16],0.343579741611421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41339,111,0.81 [0.47-1.40],0.4436526003336497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,41140,112,0.66 [0.34-1.26],0.2092518532974931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,40871,113,1.82 [0.78-4.21],0.163058008928901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,41140,112,1.20 [0.59-2.44],0.6165558296988983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,40836,112,0.92 [0.78-1.08],0.2849298972318766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,34722,92,0.79 [0.57-1.10],0.1621699343535999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,34431,93,0.67 [0.34-1.32],0.2489494204577563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,40650,108,0.88 [0.70-1.10],0.2584060788569366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,35024,96,0.93 [0.51-1.68],0.8053266670493
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,34646,90,1.04 [0.66-1.64],0.8651872405909521
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,35515,96,1.11 [0.67-1.83],0.6780521089808388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,34912,91,0.94 [0.79-1.12],0.4895002051649693
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,40768,110,1.32 [0.67-2.59],0.4231604683689689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,34553,90,0.76 [0.46-1.27],0.2983174309319186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,41529,114,0.98 [0.57-1.68],0.9380865599472608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,40992,112,1.13 [0.67-1.89],0.6421800061253142
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,34431,93,1.05 [0.74-1.47],0.792044150220018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,34646,90,0.86 [0.58-1.26],0.4328903447043816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,35607,94,0.95 [0.74-1.21],0.6830574619112622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,34431,93,0.82 [0.47-1.45],0.4953121335596558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,34646,90,0.94 [0.75-1.18],0.5681366909727372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,35024,96,1.32 [0.80-2.16],0.2747339626504045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,34553,90,0.97 [0.68-1.38],0.8669858191707945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,34553,90,0.72 [0.43-1.19],0.1993976264686239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,41391,112,0.49 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,35700,95,1.54 [0.92-2.57],0.097372056261354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,35214,92,1.41 [0.90-2.20],0.1316527640543881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,41034,110,0.84 [0.62-1.14],0.2610954468512033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,35728,94,1.32 [0.81-2.17],0.2652877158593144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,35541,92,1.01 [0.47-2.21],0.9720020362888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,35728,94,1.67 [0.45-6.15],0.439886564686698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,41132,113,0.81 [0.60-1.08],0.1492477543073773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,41146,111,1.75 [0.94-3.25],0.076945020532211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,41121,112,1.69 [0.97-2.94],0.0652077299166372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,41120,112,0.58 [0.36-0.92],0.0201097213791315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",40992,112,1.08 [0.91-1.28],0.363105162631513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",35675,94,1.07 [0.73-1.58],0.7163787155893749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",41529,114,0.79 [0.62-1.01],0.0572025357430315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,41264,112,0.98 [0.76-1.26],0.8700621661048725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,40240,112,0.97 [0.72-1.30],0.8198601209399858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,40984,113,0.81 [0.59-1.11],0.1905225013266128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,35524,95,0.87 [0.64-1.17],0.359573955865736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,35624,95,1.12 [1.00-1.24],0.0509016182553726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,35515,96,0.58 [0.25-1.35],0.2064658815694102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,34734,94,0.96 [0.69-1.32],0.793095770993079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,35675,94,0.75 [0.37-1.53],0.4288790617648916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,40836,112,1.24 [0.74-2.07],0.4108623086571693
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,35524,95,1.02 [0.81-1.29],0.8438669785335674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,41529,114,1.28 [0.70-2.35],0.4167312661878032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,34722,92,0.71 [0.51-1.00],0.0509392769766759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,41401,114,1.16 [0.65-2.07],0.6119323974543438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,41497,113,1.55 [0.99-2.41],0.0535807211054623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,35680,94,1.44 [0.76-2.73],0.2585103611228753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,34722,92,1.11 [0.79-1.54],0.5564800466731401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35675,94,1.07 [0.81-1.41],0.6524816236970605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,40984,113,0.97 [0.68-1.38],0.8700235709667525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,35624,95,1.57 [0.72-3.43],0.2548771975214308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,41034,110,1.20 [0.84-1.70],0.3148619426919533
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40857,111,1.00 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,40101,112,0.81 [0.60-1.09],0.1698965482733528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41055,112,1.03 [0.74-1.45],0.8496059228461328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,35638,95,0.89 [0.64-1.23],0.4871926272974488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,40841,111,0.63 [0.44-0.88],0.0079205969896826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,41305,112,1.10 [0.78-1.56],0.5881533192181112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,40296,112,0.93 [0.68-1.27],0.6546055480832607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,41034,110,1.01 [0.75-1.36],0.9255389508388976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,40984,113,0.82 [0.64-1.05],0.1209099978626184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40101,112,0.64 [0.47-0.87],0.0047905092732644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",34553,90,1.04 [0.76-1.41],0.8264997195970712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",34553,90,0.61 [0.40-0.94],0.0245650522581846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,40101,112,1.06 [0.83-1.34],0.6512364180055366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,40101,112,0.96 [0.67-1.38],0.8356569888113926
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,41120,112,1.17 [0.70-1.97],0.5447204850654161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,34891,89,1.07 [0.55-2.08],0.8470587364409111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",35624,95,0.93 [0.73-1.19],0.5659225445655003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,34646,90,1.21 [0.87-1.67],0.2546169649203711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,34646,90,1.05 [0.69-1.59],0.8278939087894862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,41192,113,0.92 [0.74-1.14],0.4424708752277155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,40984,113,0.85 [0.65-1.10],0.2102005998912307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,34646,90,1.17 [0.79-1.74],0.4197797941542536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,41340,112,1.03 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,41340,112,0.99 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,34646,90,1.35 [0.81-2.27],0.2496310141162717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,40296,112,1.18 [0.71-1.96],0.5121007221061784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,34646,90,1.03 [0.64-1.67],0.8897861141963616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,34431,93,0.88 [0.66-1.17],0.3811246238847936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,34366,93,1.01 [0.62-1.66],0.9567799627909914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,41140,112,1.02 [0.60-1.75],0.9413906432000292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,35680,94,0.73 [0.49-1.10],0.1340441380750737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,35607,94,1.04 [0.61-1.78],0.8778041914924007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41140,112,1.30 [0.63-2.68],0.4715435866730603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,34912,91,0.86 [0.58-1.26],0.4259046045105841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,35700,95,1.11 [0.82-1.51],0.5112011418483224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,40075,112,1.03 [0.79-1.35],0.8230001580790212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",34583,90,1.00 [0.79-1.27],0.9947122603660038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,34553,90,0.76 [0.48-1.22],0.2564687872017848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,40075,112,0.98 [0.78-1.23],0.8549430117543956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,40998,113,0.89 [0.71-1.11],0.2979103709811816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,35624,95,0.96 [0.79-1.17],0.7044164574748917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41164,112,0.93 [0.80-1.09],0.3715760272556407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40726,108,0.96 [0.65-1.42],0.8388575452173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40726,108,1.02 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39999,112,0.73 [0.48-1.10],0.1300660938453867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,35524,95,0.94 [0.67-1.31],0.7086285120138518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,40101,112,0.96 [0.82-1.12],0.5888301462369139
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40726,108,1.20 [0.67-2.16],0.5440726502459909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,40759,112,2.24 [1.33-3.75],0.0022737616047578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,40101,112,1.01 [0.59-1.73],0.9713082637712158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,41497,113,0.93 [0.56-1.52],0.7631099959451866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,41140,112,1.40 [0.86-2.29],0.1781100683010199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,40075,112,1.07 [0.85-1.36],0.5539129700977612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,40101,112,0.85 [0.52-1.39],0.5182576146524005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,35728,94,1.15 [0.55-2.41],0.7071543451529579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,35607,94,0.95 [0.62-1.46],0.8291124107422737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,35515,96,0.99 [0.57-1.72],0.9698419649573052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,34646,90,0.88 [0.70-1.10],0.2573694779365615
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,40950,111,1.14 [0.62-2.07],0.6743624120118366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,41391,112,1.55 [0.88-2.74],0.1311949139643539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,41010,111,1.01 [0.93-1.09],0.8869334718869952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,34366,93,0.67 [0.38-1.17],0.1582310417734783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,40075,112,0.91 [0.57-1.44],0.681563625807361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,34646,90,0.93 [0.59-1.48],0.767118264209296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,40984,113,0.88 [0.72-1.08],0.2165908499883247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,40101,112,0.85 [0.71-1.02],0.0756258700666171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,34553,90,0.93 [0.69-1.25],0.6339471273260534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,34722,92,0.77 [0.42-1.41],0.3951946297762849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,40595,108,0.81 [0.41-1.58],0.527505282697491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,34734,94,0.87 [0.64-1.18],0.365444722004166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FST,Follistatin,41132,113,0.87 [0.63-1.21],0.4080264069091693
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34734,94,1.04 [0.43-2.50],0.9260716256387018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,40929,112,1.15 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,35541,94,0.95 [0.74-1.21],0.6517710032920028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,41273,114,0.93 [0.75-1.14],0.4766343992420312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,34912,91,1.01 [0.72-1.40],0.967315331218106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FURIN,Furin,41140,112,1.18 [0.70-2.02],0.5343875285632419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,40040,112,0.65 [0.42-1.02],0.0592407197013268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",34954,96,1.04 [0.77-1.41],0.8069637285841472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41391,112,1.02 [0.71-1.47],0.9165198366069478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",40726,108,0.69 [0.51-0.94],0.019356882369004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",41402,112,0.89 [0.71-1.11],0.3021079215264626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,40296,112,0.84 [0.64-1.10],0.2042410412149752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,40961,110,0.90 [0.75-1.07],0.2213293597175678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,34722,92,0.95 [0.67-1.36],0.7969499888299245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,34583,90,0.88 [0.53-1.46],0.6258571076677584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,35515,96,0.87 [0.57-1.33],0.513414389194657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,35024,96,0.99 [0.74-1.32],0.9332836621049913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,34583,90,0.62 [0.40-0.95],0.0266450501801841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,34431,93,1.27 [0.59-2.73],0.5349953148923886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,34646,90,1.17 [0.80-1.72],0.4204685161482049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,35024,96,0.85 [0.53-1.35],0.4858746478727656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,34734,94,0.77 [0.52-1.15],0.2028259251108113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,34431,93,0.68 [0.45-1.02],0.05979657665174
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,41192,113,1.26 [1.08-1.46],0.0027446708193411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40836,112,1.28 [0.70-2.34],0.4285787711734589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41402,112,1.17 [0.61-2.22],0.6394477660264812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40296,112,0.97 [0.65-1.45],0.8947099819394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,35675,94,0.67 [0.32-1.40],0.2888278022593494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,40836,112,0.95 [0.43-2.13],0.905420844152559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,34553,90,1.19 [0.74-1.92],0.4767117613834655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,34147,89,0.90 [0.50-1.63],0.724305315415888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,35624,95,0.84 [0.38-1.84],0.6620843645151948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,35024,96,1.00 [0.69-1.46],0.9822245461569312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41262,113,0.79 [0.41-1.52],0.4744060491403102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,34553,90,0.99 [0.62-1.60],0.969898758900448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,35607,94,1.06 [0.92-1.22],0.4501590062394778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,34431,93,1.03 [0.48-2.19],0.937341280746123
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",34734,94,0.92 [0.71-1.19],0.519839610077588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,34722,92,1.02 [0.71-1.48],0.899644309077481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,35542,94,1.05 [0.77-1.42],0.7623926910307885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,40296,112,1.12 [0.88-1.44],0.3553791406028859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,40075,112,0.72 [0.72-0.72],0.0
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,34553,90,0.78 [0.46-1.32],0.3539559941129238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,35728,94,0.58 [0.27-1.25],0.1642104339255703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,35607,94,0.95 [0.79-1.13],0.5495140326165178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,40101,112,0.98 [0.86-1.12],0.8012447482211431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34069,89,1.09 [0.73-1.61],0.6743950834389358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,34553,90,1.16 [0.79-1.71],0.4529171573299375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40836,112,1.07 [0.65-1.75],0.7863589506412858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41529,114,1.15 [0.79-1.67],0.4627291923608984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,40075,112,0.71 [0.45-1.12],0.140421221382205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,35675,94,0.73 [0.48-1.11],0.1399768309488398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,40035,112,1.14 [0.79-1.65],0.4856418197800338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,40101,112,0.96 [0.74-1.25],0.7651830005911986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,40101,112,0.93 [0.80-1.08],0.3550856450312702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,41340,112,0.65 [0.04-9.69],0.7579690949949892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,40836,112,1.38 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,40604,108,1.27 [0.71-2.26],0.4243023670048138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,34554,90,0.78 [0.55-1.09],0.1488689863566733
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,40075,112,0.98 [0.77-1.26],0.8902298549182925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,35675,94,0.99 [0.75-1.31],0.9539658587352524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,35605,94,0.95 [0.63-1.44],0.8169022212409446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,40334,110,0.73 [0.45-1.17],0.1900333681159609
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,40726,108,1.53 [0.73-3.21],0.2611412411255375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,40101,112,1.05 [0.96-1.15],0.3182825955158994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,34912,91,1.17 [0.58-2.39],0.661171687465137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,40075,112,1.02 [0.75-1.37],0.9159767201092038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,41028,112,1.21 [0.98-1.50],0.081803913829766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,35624,95,0.98 [0.54-1.79],0.9561937376008564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,35624,95,0.91 [0.70-1.18],0.4744877921320406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,34912,91,0.87 [0.45-1.68],0.6711572868004887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,34431,93,1.13 [0.79-1.61],0.5046197202821279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,34734,94,1.08 [0.75-1.56],0.6677381726210807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35607,94,1.59 [0.86-2.97],0.1406122671774036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,35524,95,0.92 [0.75-1.11],0.378337381548701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,34646,90,0.79 [0.48-1.30],0.3515047835709665
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,34646,90,0.97 [0.79-1.20],0.7802612470991839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,34431,93,0.79 [0.55-1.15],0.2216199696874512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,39309,112,1.30 [0.71-2.39],0.3876546709484886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,34842,91,0.98 [0.57-1.70],0.9427072279073746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,40726,108,0.67 [0.44-1.04],0.0749956873942888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,34646,90,0.82 [0.43-1.57],0.5514152316400935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,40303,112,1.08 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,34583,90,0.99 [0.58-1.70],0.9722927037781136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,40756,110,1.25 [0.94-1.66],0.1195850990040384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",34912,91,0.83 [0.66-1.05],0.1221027330353639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,40075,112,1.03 [0.73-1.46],0.876534981878042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,35515,96,1.21 [0.92-1.60],0.1723197664533622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,34819,93,1.46 [1.03-2.06],0.0349405837495508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,35675,94,0.92 [0.70-1.20],0.5268424719721835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,41497,113,1.08 [0.77-1.51],0.6676871634156198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,34912,91,0.99 [0.74-1.34],0.9680424827735056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,35624,95,0.88 [0.68-1.13],0.3046925991710824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,40101,112,0.85 [0.65-1.10],0.2152844771343849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,34722,92,1.04 [0.72-1.50],0.8398554570296659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,41034,110,1.07 [0.78-1.47],0.6608910524998524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,34734,94,1.16 [0.67-1.99],0.5935346902498908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,34912,91,0.80 [0.45-1.40],0.4276319475513552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,35624,95,0.92 [0.71-1.19],0.5051336310956571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41391,112,0.85 [0.40-1.82],0.6839885734639781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40984,113,0.92 [0.79-1.08],0.330234224168784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,35524,95,0.77 [0.50-1.19],0.2370481892978292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35680,94,0.77 [0.47-1.28],0.3183022917378353
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,40849,111,0.72 [0.43-1.23],0.2317998246273944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,34553,90,0.79 [0.59-1.07],0.1329624956716828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39798,112,0.91 [0.74-1.12],0.3883992700082967
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,34912,91,0.77 [0.44-1.33],0.3417740531314489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,40961,110,0.95 [0.78-1.15],0.5949913674710992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,40836,112,1.06 [0.94-1.20],0.3603180227142806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,41402,112,1.40 [0.79-2.47],0.2499682526908642
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,40726,108,0.73 [0.64-0.84],1.3772463885245796e-05
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,35515,96,0.81 [0.54-1.21],0.3024815290942644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,35524,95,0.65 [0.38-1.14],0.1329525150745596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,35700,95,0.93 [0.61-1.42],0.7371826584370391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,35524,95,0.89 [0.68-1.15],0.3627753373106658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,40075,112,0.91 [0.50-1.64],0.7475316001683718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,34583,90,1.06 [0.77-1.45],0.7130852429094618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,35624,95,1.10 [0.65-1.86],0.7213401424840324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,35524,95,0.79 [0.57-1.09],0.1510690167033161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,40303,112,0.91 [0.71-1.16],0.4315815028225849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,35515,96,0.91 [0.62-1.31],0.6006350392566036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,35675,94,0.93 [0.68-1.27],0.6446745969004204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",35624,95,1.01 [0.64-1.59],0.9641559463743202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",34583,90,0.93 [0.64-1.36],0.7166679234522467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,40303,112,0.83 [0.58-1.20],0.3268432394414439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,40837,109,1.25 [0.61-2.56],0.5382873522251208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,34734,94,0.80 [0.55-1.15],0.2262529436168179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",40836,112,0.77 [0.57-1.05],0.0951524628254311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,34238,93,0.81 [0.62-1.05],0.1176126749776106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,40101,112,0.91 [0.73-1.14],0.4169053195226012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,35563,95,1.68 [0.61-4.66],0.3179023040842922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",35497,95,0.81 [0.33-1.97],0.6417632084090146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,40101,112,0.92 [0.71-1.19],0.5197561780047353
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,34553,90,1.02 [0.77-1.34],0.9025528892291445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,39826,112,0.88 [0.68-1.14],0.3309988186298078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,35607,94,1.02 [0.94-1.11],0.6682086604358421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35024,96,1.01 [0.77-1.32],0.9647603090813874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,34722,92,0.83 [0.64-1.07],0.1473271178037717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,40824,110,1.05 [0.62-1.75],0.8667850271446788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,35024,96,0.98 [0.77-1.25],0.8666046421873066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,34553,90,1.10 [0.69-1.75],0.7034532622359672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,41215,114,0.94 [0.72-1.23],0.6495327485430624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",40303,112,0.91 [0.76-1.10],0.3275354045586889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,41497,113,0.92 [0.56-1.49],0.7261066366770358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,40984,113,0.84 [0.64-1.10],0.2049793030872909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,40303,112,1.12 [0.95-1.31],0.1849274666909051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,34431,93,0.98 [0.66-1.46],0.9160978585580324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34553,90,0.74 [0.48-1.12],0.1505375575002712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41280,111,1.08 [0.86-1.36],0.4836018613075569
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,41402,112,1.03 [0.91-1.16],0.6805199038832634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",41034,110,0.97 [0.78-1.21],0.814006788388465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,41342,111,1.13 [1.11-1.15],1.0521771589253148e-37
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41034,110,1.22 [0.78-1.91],0.39001072064967
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,41280,111,0.85 [0.68-1.07],0.1727349002529763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,41402,112,1.24 [0.96-1.60],0.0971287359583358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,35675,94,1.05 [0.87-1.26],0.6089050422852125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,34553,90,1.03 [0.72-1.48],0.8582528204624303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,41497,113,0.99 [0.73-1.33],0.9240374750136068
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,34646,90,0.99 [0.72-1.37],0.9565574904659598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,34583,90,0.94 [0.67-1.31],0.7089751307013336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,35524,95,1.22 [0.79-1.87],0.3661731973452782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,41338,112,0.97 [0.82-1.16],0.7670012674258796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,35607,94,1.24 [0.93-1.64],0.1420256430188651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,40303,112,1.09 [0.83-1.44],0.5406365027922663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,34912,91,0.68 [0.32-1.47],0.3285984137184262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,35607,94,1.07 [0.67-1.71],0.786933671632262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,35675,94,0.89 [0.44-1.83],0.752687799816696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,40984,113,0.89 [0.72-1.09],0.2576242069510824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,41497,113,0.81 [0.33-1.95],0.6332255393194675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,35367,95,1.31 [0.64-2.70],0.4646435319103394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,40101,112,0.92 [0.74-1.15],0.4673874244358388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,35607,94,0.88 [0.67-1.14],0.3259184515561161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,34646,90,1.14 [0.88-1.48],0.3257617386221176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,34553,90,0.99 [0.55-1.80],0.976387883449322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35537,94,1.06 [0.69-1.63],0.796916601671652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,35624,95,1.01 [0.66-1.57],0.9469610014506328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,40303,112,0.97 [0.53-1.77],0.924309870459356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",35624,95,1.14 [0.63-2.09],0.6657534174721096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",40856,113,0.85 [0.54-1.35],0.498901608569366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",40984,113,1.29 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,41402,112,1.52 [1.03-2.23],0.0332326863458356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,34846,91,1.08 [0.76-1.54],0.6790762551529765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",34734,94,0.89 [0.59-1.35],0.5863980807998046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",34553,90,0.87 [0.54-1.43],0.5928890342284404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,34365,93,0.87 [0.56-1.36],0.5484905766462003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,40581,111,1.17 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,40075,112,0.87 [0.59-1.27],0.4689442544077011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,34722,92,0.99 [0.75-1.32],0.9683800860596984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,40524,108,0.94 [0.67-1.32],0.7050669901851985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,40173,112,0.90 [0.72-1.12],0.3452476155056871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,35624,95,0.92 [0.61-1.39],0.692350221089618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,41497,113,0.93 [0.75-1.16],0.5371701426902753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,40101,112,0.95 [0.60-1.49],0.8260243171417959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,35209,94,1.01 [0.82-1.25],0.9237142945784096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,34959,96,1.09 [0.92-1.29],0.3032714784696774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,34734,94,1.11 [0.63-1.93],0.7225820720170942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,35541,92,0.90 [0.47-1.69],0.7364907903139344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,34734,94,0.86 [0.68-1.07],0.1823817115876599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40836,112,1.00 [0.64-1.56],0.9914768936885208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41402,112,1.38 [0.89-2.14],0.1527801157135445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,34646,90,1.51 [0.84-2.70],0.1666177174663264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,34734,94,0.81 [0.66-1.00],0.0553340197390547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40984,113,0.68 [0.53-0.87],0.0020632426974274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,35607,94,0.95 [0.69-1.31],0.7762210480792493
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,34553,90,1.28 [0.90-1.83],0.1671585188740696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,34734,94,0.85 [0.55-1.30],0.4447915744760424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,39890,112,0.84 [0.61-1.17],0.311884133633062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,35515,96,0.90 [0.50-1.64],0.733711872245228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,40371,110,0.90 [0.72-1.14],0.4006540963934666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,41402,112,1.23 [0.83-1.82],0.2991434307773923
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40721,111,1.48 [0.91-2.40],0.1161538904209696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,34583,90,0.92 [0.69-1.23],0.5829655390574018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,34583,90,0.91 [0.56-1.47],0.6912602761701084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",41140,112,0.89 [0.68-1.18],0.415169017351365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,40789,111,0.72 [0.36-1.47],0.3691778553436016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,41529,114,1.49 [0.71-3.12],0.2873816589777136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,40296,112,0.85 [0.68-1.06],0.1475180968723131
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,40855,111,1.08 [0.65-1.80],0.770879082134159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41529,114,0.93 [0.56-1.56],0.7931414843246345
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41529,114,1.11 [0.59-2.10],0.7519297070061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,40984,113,0.87 [0.59-1.29],0.4953766904316063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,40836,112,2.00 [0.82-4.89],0.1296578322997808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,35024,96,1.18 [0.81-1.71],0.3808259946501997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,40075,112,1.02 [0.72-1.45],0.8986228204020714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",34734,94,0.69 [0.50-0.96],0.0283146372823847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,41497,113,2.24 [0.35-14.17],0.3919888879809963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,41402,112,0.86 [0.60-1.22],0.3854732851028872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34678,92,0.77 [0.45-1.32],0.3367250979196031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,35024,96,0.87 [0.59-1.29],0.4863843782750245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,35024,96,1.18 [0.72-1.92],0.5153090009360101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,35524,95,0.80 [0.36-1.76],0.5769913415627461
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,40296,112,1.06 [0.91-1.22],0.4665717683234763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41192,113,1.35 [0.39-4.65],0.6379924688680234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,40726,108,1.15 [0.83-1.59],0.3940275691242525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,40075,112,1.21 [0.87-1.69],0.2638551749761672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,34583,90,1.06 [0.79-1.44],0.685738378940804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,40984,113,0.89 [0.65-1.22],0.4693040456363031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,34553,90,0.86 [0.47-1.60],0.6395939748189564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,34722,92,0.63 [0.38-1.04],0.0726326634339302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,35624,95,1.03 [0.75-1.42],0.8693542753394714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,34583,90,1.06 [0.71-1.59],0.7574436356455352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,35680,94,0.45 [0.23-0.89],0.0214352844473978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,40836,112,0.99 [0.46-2.15],0.9868473032976912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,34553,90,1.06 [0.71-1.59],0.7755334337792124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,41034,110,0.99 [0.48-2.04],0.973391333133383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,41465,114,1.07 [0.93-1.24],0.3542374124770633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,41459,113,1.06 [0.77-1.45],0.7160213169367688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,41179,112,0.95 [0.53-1.68],0.8524469670442011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,40515,109,1.07 [0.88-1.32],0.4950343493154157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,40848,111,1.30 [0.74-2.28],0.3686579509384144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41529,114,1.11 [0.66-1.88],0.6970411392325991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,41028,112,1.29 [0.79-2.09],0.3067529499350783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,34646,90,1.06 [0.82-1.36],0.6460816397916045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,34553,90,1.04 [0.74-1.46],0.8182845459195525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,35665,92,0.47 [0.16-1.41],0.1775736397463598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,34431,93,1.05 [0.86-1.28],0.60665481541689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,34734,94,0.91 [0.54-1.55],0.7387188699028696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,40836,112,1.03 [0.64-1.66],0.9169689582575746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,35675,94,1.09 [0.86-1.39],0.4755821655538838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,40984,113,0.93 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,40101,112,0.91 [0.75-1.12],0.3919680509864213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,40296,112,0.96 [0.78-1.19],0.7110410591901022
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,40296,112,0.98 [0.73-1.31],0.8658945081236632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41192,113,1.35 [0.78-2.31],0.2833264274704794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,40296,112,0.99 [0.76-1.30],0.9618876560140268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,40836,112,1.22 [1.07-1.40],0.003692928079038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41497,113,1.41 [1.07-1.86],0.0135734053163667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,40296,112,1.37 [0.89-2.10],0.1498087502143061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,34646,90,1.06 [0.66-1.71],0.7982966359840694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,40296,112,0.96 [0.67-1.37],0.8241278553534496
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,40499,109,1.13 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,34583,90,1.13 [0.56-2.28],0.7421477342731491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,40984,113,1.21 [0.73-1.99],0.4593079395412837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,40296,112,1.10 [0.68-1.79],0.687557036303307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,41497,113,0.90 [0.62-1.33],0.6034303045491021
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,40232,112,0.92 [0.61-1.39],0.6936592022613056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,40296,112,1.18 [0.96-1.44],0.1076908408225834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,40296,112,1.18 [0.77-1.81],0.4431319674797785
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,40296,112,1.13 [0.91-1.41],0.2677664594368116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,41034,110,0.77 [0.52-1.12],0.1669799432582253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,40466,111,0.80 [0.58-1.09],0.1584718196875413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,40854,112,1.07 [0.76-1.52],0.6971733295301781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41179,112,1.24 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41497,113,1.08 [0.65-1.79],0.7779132020378571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,40466,107,0.98 [0.90-1.07],0.6812372685149529
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,40296,112,0.90 [0.65-1.24],0.5258029283390886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,40109,111,0.93 [0.68-1.27],0.6396811348428054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,40968,109,0.98 [0.46-2.11],0.9601425343249078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,40934,112,0.54 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,41034,110,1.70 [1.20-2.42],0.002991454012367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,41401,114,0.91 [0.64-1.30],0.6102001368175427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,40296,112,0.88 [0.59-1.30],0.5147088493675486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,40296,112,0.94 [0.55-1.60],0.8066046045882153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,40296,112,0.94 [0.66-1.33],0.7177438012623885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,40296,112,0.93 [0.63-1.38],0.711671449375954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,34646,90,0.85 [0.52-1.40],0.5288734517353959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,34646,90,1.47 [1.18-1.84],0.000619061212478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,35515,96,1.01 [0.76-1.35],0.9458646967484626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,40296,112,0.85 [0.56-1.29],0.4456484921214381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,40296,112,1.05 [0.75-1.46],0.7775491002469839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,34303,93,0.67 [0.38-1.18],0.1625672106339494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,40742,112,1.18 [0.76-1.82],0.4569517334972993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,40296,112,1.07 [0.70-1.64],0.7458869670774779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,35515,96,1.21 [0.77-1.90],0.4027734799647242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,34431,93,0.88 [0.65-1.19],0.4000758410459054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,34646,90,1.31 [1.00-1.71],0.0468934237880361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,34515,90,0.94 [0.56-1.58],0.8281288186291285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,40984,113,1.04 [0.70-1.54],0.8516086089582001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,40296,112,0.94 [0.61-1.43],0.7636669610185411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,40015,112,0.92 [0.58-1.46],0.7145880761933792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,34646,90,1.00 [0.70-1.42],0.9807059798400876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,34518,89,0.99 [0.73-1.34],0.9334828193805418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,40296,112,1.02 [0.60-1.74],0.9285631016351736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,40296,112,0.96 [0.81-1.14],0.6397215981656688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,40984,113,1.18 [0.75-1.87],0.4800663378098886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,40296,112,1.01 [0.90-1.13],0.8910227048977162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,40984,113,0.87 [0.64-1.18],0.374197569967589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,40836,112,0.97 [0.79-1.19],0.7579915739739668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,40786,111,0.95 [0.58-1.56],0.8396070550882175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,40984,113,0.86 [0.66-1.11],0.2503993866362838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,41034,110,1.27 [0.92-1.74],0.1453980847265934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,35024,96,1.38 [1.08-1.76],0.0093500178504167
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,40019,112,0.82 [0.60-1.11],0.194700536656567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35515,96,1.01 [0.65-1.57],0.9723593138910032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,40726,108,0.89 [0.67-1.18],0.4199631308739782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,35607,94,0.90 [0.63-1.28],0.5627326660425619
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,34583,90,1.00 [0.51-1.95],0.9969042950691076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,39999,112,1.10 [0.78-1.55],0.5856069192654405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,34912,91,0.95 [0.64-1.42],0.8118693493115459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,41034,110,1.04 [0.73-1.50],0.8159585460687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,40836,112,0.81 [0.59-1.12],0.1982492873867232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34734,94,0.87 [0.61-1.25],0.4511015915703741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",35624,95,1.25 [0.85-1.83],0.2489345666963659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40836,112,0.96 [0.81-1.14],0.6420168563662298
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,35607,94,1.12 [0.85-1.48],0.4206703256099988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,35515,96,1.11 [0.79-1.57],0.5417247887478464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,35524,95,0.88 [0.71-1.09],0.2456119785354747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,34646,90,1.17 [0.35-3.95],0.7976628567707831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,40657,108,0.97 [0.88-1.06],0.5219125554719496
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,40836,112,0.90 [0.66-1.24],0.5266202915014517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40303,112,1.05 [0.87-1.26],0.6053121476570329
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,40296,112,0.89 [0.69-1.13],0.3339664713936546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,40984,113,0.97 [0.83-1.14],0.6990245500313741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39492,111,0.60 [0.38-0.96],0.0318784840501272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,35680,94,0.86 [0.54-1.39],0.5487557674869414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,35258,95,0.90 [0.74-1.10],0.2937712688965688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,40984,113,1.13 [0.69-1.83],0.6268270545874516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,34912,91,1.24 [0.68-2.26],0.4766783059543763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41034,110,0.94 [0.49-1.80],0.8403118497108539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,40984,113,0.91 [0.66-1.25],0.554110362528178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,34646,90,0.96 [0.60-1.52],0.861904612434321
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,41034,110,1.49 [0.89-2.50],0.1281206403236011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,41402,112,1.12 [0.40-3.13],0.8274198005820842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,35024,96,0.76 [0.51-1.14],0.1782657639870531
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,40986,112,1.19 [0.56-2.50],0.6507524088198289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,40101,112,0.81 [0.54-1.22],0.3077552309498016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,40303,112,0.96 [0.82-1.11],0.5523400031458194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,40791,112,1.36 [0.79-2.32],0.267549272776013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,41140,112,0.82 [0.52-1.30],0.404560356470752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,40296,112,1.31 [0.75-2.27],0.3410208854024323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,41402,112,1.13 [0.80-1.62],0.4845143165902901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35680,94,1.26 [0.74-2.16],0.3992450167088179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35728,94,1.77 [0.69-4.55],0.2362788835758906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41179,112,1.04 [0.67-1.63],0.856761417056322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35728,94,1.10 [0.52-2.32],0.8113875684928542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,35515,96,1.07 [0.71-1.63],0.7409739470404393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,40984,113,0.89 [0.59-1.34],0.5759472026301007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,34553,90,1.02 [0.76-1.39],0.8737413654278712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34734,94,0.96 [0.72-1.29],0.7879849272075468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",34583,90,0.99 [0.64-1.55],0.9765635541265268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",40075,112,0.94 [0.66-1.32],0.7073456671345528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,34431,93,0.87 [0.54-1.38],0.5492814967246551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,41391,112,1.47 [0.80-2.70],0.2191402986332857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,34912,91,0.76 [0.49-1.17],0.2156423105670424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,40296,112,0.82 [0.62-1.09],0.1761760358051762
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,34431,93,0.88 [0.60-1.28],0.4883685840174506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,35524,95,0.87 [0.70-1.09],0.2336943236829939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,40296,112,1.00 [0.72-1.39],0.993560931749698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40836,112,1.09 [0.75-1.58],0.6665840065217772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,35524,95,0.94 [0.78-1.13],0.5184064439672692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,34583,90,0.79 [0.52-1.22],0.2956400869661134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,34722,92,0.91 [0.68-1.21],0.520572070642086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,40075,112,1.01 [0.73-1.41],0.9431505144054024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,34931,94,1.17 [0.77-1.77],0.4631691439862546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,34646,90,0.87 [0.67-1.13],0.2972157586683343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,41140,112,2.10 [1.06-4.16],0.0324680757544846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,40075,112,1.57 [0.98-2.51],0.059188566238103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,34431,93,0.85 [0.60-1.21],0.3767432777432572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,34734,94,0.95 [0.69-1.30],0.7566975447739988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,35607,94,1.46 [0.82-2.58],0.1973130743456481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,35024,96,1.15 [0.89-1.50],0.2868431149461488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,35024,96,0.86 [0.43-1.76],0.6863073630968355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,35515,96,1.21 [0.92-1.59],0.1738783059804475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,34553,90,0.72 [0.37-1.40],0.3310194904387475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,34583,90,0.99 [0.76-1.29],0.9685392264038846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,34553,90,1.04 [0.88-1.23],0.6509726379056366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,40836,112,0.96 [0.78-1.18],0.705445362323164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,35515,96,0.87 [0.69-1.09],0.2117289073138284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,40101,112,0.85 [0.68-1.07],0.1641112455911595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,35524,95,0.97 [0.86-1.09],0.5888874106655645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,40101,112,1.01 [0.88-1.15],0.894246410118195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34431,93,0.87 [0.66-1.16],0.3423487293426177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,34583,90,1.08 [0.79-1.48],0.6113380256394088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,40075,112,0.84 [0.54-1.33],0.4624492974490685
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,41120,112,0.69 [0.39-1.22],0.1980162773669102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,40075,112,1.06 [0.85-1.31],0.6301427383678156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,34583,90,1.30 [0.84-2.01],0.2454486455923014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,35624,95,1.08 [0.73-1.58],0.7067791875856213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,40613,109,1.12 [0.99-1.27],0.0754751184849644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,41015,112,0.91 [0.59-1.39],0.6480472304197916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,40733,112,1.42 [0.90-2.22],0.128600441214261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,40101,112,1.03 [0.91-1.17],0.6077291214799869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,40100,110,0.92 [0.63-1.35],0.6826375270132843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,41402,112,0.88 [0.61-1.26],0.4767902078848488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,35459,96,1.43 [0.99-2.07],0.0533774956546957
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,35680,94,1.27 [1.01-1.58],0.037632696949533
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,41402,112,1.10 [0.93-1.30],0.2687191001686284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,41076,112,1.17 [0.67-2.02],0.5864504104448445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,34012,91,0.68 [0.39-1.17],0.1647556145775829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,35011,90,2.14 [0.97-4.71],0.058234888434221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41497,113,1.12 [0.72-1.75],0.6135236936881816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,34583,90,1.09 [0.80-1.48],0.5981829016957404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,41497,113,1.07 [0.76-1.51],0.7112695251701274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,34646,90,0.71 [0.40-1.25],0.234397887894981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,35607,94,1.11 [0.73-1.70],0.6184362681674922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",38799,109,0.69 [0.36-1.32],0.2630876429681036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",34553,90,0.77 [0.44-1.35],0.3549158891109979
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",40836,112,1.05 [0.85-1.31],0.6397506867866225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",40920,113,1.14 [1.06-1.21],0.0001373572196031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",40075,112,1.47 [1.10-1.95],0.0081022505423119
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",34553,90,1.02 [0.61-1.71],0.9400268599014494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",34583,90,1.13 [0.87-1.47],0.3522606482759788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,41497,113,0.83 [0.56-1.22],0.3392170421078325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,41140,112,1.01 [0.56-1.80],0.9801937721344472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,35675,94,0.92 [0.73-1.15],0.4455314400133657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,35444,96,0.96 [0.64-1.44],0.8598298595328875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,40836,112,1.24 [0.83-1.86],0.2900624628991813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40992,112,1.06 [0.66-1.72],0.801967274238875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40726,108,1.04 [0.88-1.23],0.644676519568171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,34553,90,1.05 [0.73-1.50],0.8013921568176623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,41192,113,0.86 [0.52-1.43],0.5574832828969593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,34734,94,1.18 [0.61-2.31],0.6190872643128862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,34700,93,1.36 [0.88-2.10],0.169293690861366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,39784,108,1.56 [0.64-3.79],0.327702992823112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,41424,113,0.93 [0.67-1.28],0.6484134252635505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,35515,96,1.10 [0.70-1.72],0.6764324673921027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,40296,112,0.95 [0.67-1.35],0.7766132156447694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,35515,96,0.87 [0.62-1.21],0.4033063234873962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,41497,113,0.94 [0.50-1.76],0.8403996290612323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,40836,112,0.94 [0.82-1.07],0.3490617954571186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,34646,90,0.89 [0.70-1.14],0.3521737975945472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40650,108,1.19 [0.72-1.95],0.4985519510795378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,41179,112,1.20 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,41391,112,0.99 [0.78-1.26],0.9519034800371444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,35700,95,1.35 [0.55-3.32],0.5168435664100972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,35624,95,1.12 [0.83-1.50],0.4593797823747667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,39800,111,0.95 [0.60-1.49],0.8172472771430944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,35680,94,0.57 [0.35-0.90],0.0162447265687164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,41138,114,1.11 [0.81-1.52],0.5229693169243994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,35624,95,0.89 [0.72-1.08],0.2384529780685028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,35675,94,1.10 [0.82-1.48],0.5399432727964292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,41340,112,1.08 [0.78-1.50],0.6510090371977852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,33711,88,0.87 [0.63-1.19],0.3701467460124235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,34583,90,1.06 [0.81-1.38],0.6795523264869299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,35624,95,0.98 [0.52-1.84],0.9483134071389208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,35624,95,1.17 [0.82-1.67],0.3750736714007029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,41136,112,0.89 [0.51-1.54],0.6771186177702744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35728,94,1.60 [0.93-2.76],0.0882478993568177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,40992,112,1.28 [0.96-1.72],0.095953205755968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,40961,111,0.85 [0.51-1.40],0.5147629128378447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,41391,112,0.91 [0.69-1.21],0.5071430317629038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,41006,113,0.80 [0.51-1.26],0.3363623798196433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,41192,113,0.87 [0.55-1.39],0.5674882908529842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,40101,112,0.93 [0.75-1.14],0.4795288196890346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41054,113,1.10 [0.83-1.44],0.5029802399863916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,40075,112,0.89 [0.63-1.26],0.5048010410432192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,40984,113,0.94 [0.47-1.89],0.8671611056517627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41034,110,1.06 [0.66-1.69],0.8164945619306961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,35680,94,0.90 [0.81-1.01],0.0766825924792973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,34553,90,1.05 [0.71-1.54],0.8038262208528106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40974,112,0.73 [0.42-1.25],0.249568579165799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,35675,94,0.87 [0.67-1.14],0.3236775764362809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41529,114,0.88 [0.48-1.61],0.6696663335265085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41331,113,0.67 [0.42-1.08],0.0984723694918008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40296,112,1.16 [0.78-1.70],0.4670658251574308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41529,114,1.19 [0.93-1.52],0.1621832086731353
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,34734,94,1.32 [0.97-1.80],0.0746173555521807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,35454,95,0.90 [0.65-1.26],0.5438880330361502
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,35607,94,0.90 [0.44-1.84],0.7689200226029447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,35624,95,1.33 [0.82-2.17],0.252551071746198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,34583,90,0.99 [0.72-1.37],0.9487229824922908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",34734,94,0.92 [0.72-1.16],0.4621981287905206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),34880,90,0.98 [0.88-1.10],0.765189723165579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,40836,112,1.28 [0.97-1.69],0.0773382498329314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,39683,106,1.01 [0.75-1.35],0.9551690894863604
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,34553,90,0.94 [0.69-1.29],0.7159778867103698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34553,90,0.86 [0.63-1.17],0.3389805345702072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,34722,92,0.77 [0.47-1.28],0.3136079956859953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,35728,94,1.98 [0.97-4.04],0.0593941047204673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41280,111,0.81 [0.50-1.32],0.4066932034075117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,34523,90,1.29 [0.69-2.40],0.4286617184959752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,40836,112,1.09 [0.59-2.03],0.7750679187169656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,34722,92,0.99 [0.57-1.71],0.9729309367268192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,34722,92,1.08 [0.87-1.34],0.4814147326049584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41391,112,0.79 [0.56-1.11],0.1758865931880953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,40836,112,1.01 [0.66-1.55],0.9730378048442672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,35524,95,1.30 [0.83-2.06],0.2556584094409984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,34722,92,0.95 [0.62-1.44],0.7962706593509742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,35675,94,0.89 [0.58-1.37],0.595315001234677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,35515,96,0.96 [0.64-1.44],0.850721565970617
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,40296,112,1.47 [0.97-2.23],0.071112398391388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,34722,92,1.19 [0.77-1.83],0.4424222985618438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,35624,95,0.78 [0.36-1.69],0.5243135515104869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,40101,112,0.77 [0.54-1.09],0.1357313448050034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,35024,96,1.07 [0.87-1.31],0.5407849745069362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,40984,113,0.87 [0.59-1.27],0.4631497006922457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,40984,113,0.95 [0.63-1.45],0.8190610008644813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,41402,112,0.93 [0.65-1.33],0.6863707658972712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,35515,96,0.97 [0.55-1.72],0.9177970119490227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41529,114,1.23 [0.71-2.11],0.459649466903244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,40101,112,0.99 [0.72-1.36],0.9592268912465828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,40798,112,1.00 [0.54-1.82],0.9882883297834638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,40296,112,1.14 [0.79-1.65],0.4803830319940951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,35515,96,1.24 [0.84-1.83],0.277718649814244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LXN,Latexin,40539,107,1.11 [0.87-1.42],0.394273802437673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,40984,113,0.87 [0.57-1.32],0.5125834537409725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40581,111,1.13 [0.64-2.00],0.683219119612314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,40726,108,0.72 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,40101,112,1.15 [0.89-1.50],0.2885150001777583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,40836,112,0.94 [0.77-1.14],0.5087392121127496
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,40075,112,0.84 [0.61-1.16],0.2971403383650945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,40813,112,1.01 [0.61-1.67],0.9754580923917682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,40101,112,0.86 [0.61-1.23],0.4100361645609867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,34583,90,1.09 [0.93-1.29],0.2897378547380437
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,34722,92,0.85 [0.68-1.06],0.1396489095770825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,35728,94,1.09 [0.40-2.98],0.8668105423932939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,34431,93,1.14 [0.67-1.93],0.6355784548773102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,34912,91,0.86 [0.65-1.15],0.3181086224142239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,34734,94,0.94 [0.57-1.56],0.8136647697477012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40585,108,1.06 [0.77-1.47],0.7157944964986458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,40101,112,0.99 [0.64-1.51],0.9511280109727936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,34722,92,0.86 [0.56-1.32],0.4950988137669805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,35024,96,0.90 [0.73-1.11],0.3200519005418477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,40101,112,0.98 [0.69-1.40],0.9243819316407762
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,35675,94,1.07 [0.60-1.89],0.8183152679582943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,35515,96,1.25 [0.89-1.77],0.2015377865868752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34734,94,0.92 [0.42-2.00],0.8255798515245849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,35675,94,0.75 [0.54-1.04],0.0860513501520678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",34431,93,1.02 [0.68-1.51],0.938635493491557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,41192,113,0.96 [0.84-1.09],0.517672213391441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,41140,112,0.87 [0.47-1.62],0.664332974224494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,34553,90,1.03 [0.76-1.39],0.8618732615782053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,34583,90,1.16 [0.62-2.19],0.6431975466755862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,34553,90,0.71 [0.45-1.11],0.1290743913486643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,35607,94,0.91 [0.58-1.43],0.6946193133741831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,35524,95,0.90 [0.66-1.22],0.4851037830859945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40984,113,0.95 [0.80-1.12],0.5109739707756938
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,40101,112,0.95 [0.80-1.14],0.6040274925417988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40650,108,0.94 [0.93-0.96],5.808403003030439e-15
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,34431,93,1.41 [1.01-1.97],0.0428015655033212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,40984,113,0.78 [0.54-1.13],0.1894110919643998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,35024,96,0.90 [0.69-1.18],0.446054772600355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,34431,93,0.96 [0.83-1.10],0.5330480800351795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,40075,112,0.89 [0.61-1.29],0.5294211868496919
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",34842,91,0.94 [0.74-1.19],0.5962431026933949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,40650,108,1.86 [0.87-3.97],0.1089579921834991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,41065,113,0.72 [0.41-1.28],0.2613335175057687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,40657,108,0.84 [0.49-1.45],0.5314644109562519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,40101,112,0.88 [0.73-1.07],0.1979590615466276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAX,Protein max,40075,112,0.93 [0.80-1.10],0.4104047460289574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,41529,114,1.22 [0.92-1.60],0.1616369096862169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,35224,91,1.14 [0.94-1.38],0.1851515881927892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,41179,112,1.26 [0.77-2.05],0.3580849414637006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",35624,95,0.99 [0.62-1.58],0.9740923704757134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,34646,90,0.73 [0.57-0.93],0.010514893806364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,35524,95,0.41 [0.16-1.01],0.0529803370944205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40726,108,1.11 [0.86-1.43],0.4110202034710742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",35497,95,0.90 [0.55-1.48],0.6764855332918625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDK,Midkine,41017,111,0.76 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,34722,92,0.99 [0.52-1.89],0.974555245156166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",34734,94,0.87 [0.70-1.09],0.2301610742275625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,40101,112,0.90 [0.73-1.11],0.3363809231151298
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,34553,90,1.22 [0.88-1.69],0.2347048275550504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,40992,112,1.26 [0.81-1.95],0.3074719396050951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,34553,90,0.81 [0.41-1.58],0.5330633918469713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,41401,114,1.08 [0.49-2.38],0.8483389628629756
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,35675,94,0.98 [0.50-1.93],0.9569549547285204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,34912,91,1.32 [0.53-3.29],0.5492995253307289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,35524,95,0.82 [0.62-1.10],0.1902693598605582
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,40992,112,0.74 [0.38-1.44],0.3812936530634385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,41497,113,1.20 [0.61-2.36],0.6053743076022058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,41034,110,0.94 [0.82-1.08],0.3876740813395655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,41133,114,0.69 [0.30-1.55],0.3656707086177171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,40075,112,0.88 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40984,113,0.86 [0.70-1.05],0.1420590693701539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,41340,112,0.95 [0.71-1.27],0.7201929500487843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,40303,112,1.15 [0.84-1.57],0.3710808417545912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,34722,92,0.97 [0.71-1.33],0.8580176162983459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,34912,91,1.13 [0.60-2.12],0.7130944239236872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,41529,114,1.39 [0.96-2.01],0.0820856359166112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,41034,110,0.86 [0.58-1.28],0.4550736682122086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,41132,113,0.91 [0.76-1.10],0.3392203695759836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,40984,113,1.01 [0.88-1.16],0.8492539710771743
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,41140,112,1.20 [0.87-1.67],0.264859392239152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,34722,92,1.02 [0.76-1.36],0.8962979463130948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40984,113,1.00 [0.89-1.12],0.9851617160006492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,40969,110,1.05 [0.82-1.35],0.6968628916963351
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40296,112,1.11 [0.76-1.62],0.5941311785211689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,35515,96,0.97 [0.81-1.16],0.7201478715431044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,35607,94,0.95 [0.77-1.18],0.6583451080986142
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,40726,108,0.93 [0.78-1.11],0.4279835205005152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,34646,90,1.01 [0.61-1.65],0.9788894738715916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,34431,93,1.12 [0.86-1.46],0.4090016146604351
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,40984,113,1.02 [0.85-1.22],0.8433867264443577
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,40836,112,0.95 [0.74-1.20],0.6491197021657737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,39549,109,0.99 [0.82-1.19],0.9144656026524448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,40939,113,0.89 [0.69-1.16],0.3918333682171562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,41090,110,1.19 [0.85-1.65],0.3140729630013126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,40075,112,0.67 [0.40-1.13],0.1302717505205041
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,35675,94,1.23 [0.91-1.67],0.1709518187458318
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,41034,110,1.01 [0.71-1.43],0.9688727039921284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,40236,110,0.80 [0.58-1.11],0.1885987956075201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,41321,112,0.96 [0.77-1.20],0.721527618414165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,40973,110,1.01 [0.75-1.36],0.9576459530520066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34553,90,0.72 [0.46-1.12],0.142326625912616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,34722,92,1.30 [1.00-1.69],0.0479691369544458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,35024,96,1.23 [0.84-1.81],0.2836956873090056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,40964,112,1.14 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,34912,91,0.72 [0.52-0.99],0.0409171973869149
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,41402,112,1.33 [0.80-2.21],0.2768577125165233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,35607,94,1.05 [0.53-2.09],0.8920979154687595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,35024,96,1.17 [0.77-1.77],0.4676383628814354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,34431,93,0.61 [0.32-1.14],0.1197098287030585
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,34431,93,0.92 [0.70-1.22],0.5607674959322104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,40303,112,1.08 [0.87-1.34],0.4945266853590314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,40836,112,0.93 [0.76-1.14],0.5016582362110268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41132,113,0.89 [0.72-1.09],0.2574892911495829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,41034,110,1.18 [1.07-1.30],0.0006999640849469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,35445,96,1.42 [0.98-2.04],0.0617625945424453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,35700,95,1.00 [0.50-2.01],0.99802306658571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,34722,92,1.13 [0.84-1.52],0.4192772202474433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",34553,90,0.87 [0.49-1.53],0.6195657186715222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",35624,95,0.84 [0.45-1.56],0.5709554167862654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",40075,112,0.58 [0.30-1.14],0.1166987811586989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",34365,93,0.44 [0.19-0.98],0.0445354575785425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",35624,95,0.79 [0.57-1.10],0.1591986095231615
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",34646,90,0.58 [0.25-1.36],0.2109759778729703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,40774,111,0.92 [0.67-1.25],0.5903066314843145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,34722,92,1.47 [0.94-2.28],0.088960132327244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,40921,111,1.17 [0.92-1.50],0.1982118933068739
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,41391,112,0.84 [0.60-1.16],0.2857501998902421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,41140,112,0.93 [0.74-1.17],0.550764223534822
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,35159,93,1.15 [0.80-1.64],0.4442044279323475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,40303,112,1.01 [0.73-1.40],0.9500088014278184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,34646,90,0.93 [0.74-1.16],0.5065511391494922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",35607,94,0.61 [0.26-1.45],0.2642217333732518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,35024,96,0.97 [0.81-1.15],0.7076590148449172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",35524,95,0.96 [0.77-1.20],0.7204856950677901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,40303,112,0.63 [0.35-1.14],0.1280054183412451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,34553,90,0.91 [0.65-1.27],0.5828943550259691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,35524,95,0.99 [0.83-1.18],0.897517471469841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,35515,96,0.86 [0.70-1.05],0.1269721912257942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,35024,96,0.76 [0.52-1.12],0.1659851049018731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,40075,112,1.02 [0.71-1.45],0.9309395251129032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,40836,112,0.99 [0.91-1.08],0.8382579611746267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,35680,94,0.90 [0.73-1.12],0.3627647934592942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,34431,93,0.89 [0.54-1.46],0.6435067086755413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,40296,112,0.98 [0.79-1.21],0.8490749374062965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,34912,91,1.00 [0.51-1.94],0.9903511261757524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",35675,94,1.21 [0.93-1.57],0.1610314476792637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",34734,94,1.02 [0.80-1.28],0.8994220242089572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,35624,95,0.79 [0.57-1.10],0.1572042317570859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,35675,94,0.95 [0.78-1.16],0.6117502999709392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,34553,90,1.22 [0.84-1.77],0.3067957474391692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,34431,93,0.97 [0.61-1.54],0.901089149285212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,35680,94,1.01 [0.85-1.20],0.9170583057912136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",34553,90,1.12 [0.71-1.78],0.6327004675583233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,34734,94,1.22 [0.93-1.59],0.1454301654367001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,34734,94,1.28 [0.92-1.76],0.139808515772017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,34722,92,0.96 [0.76-1.20],0.6989156339816069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",34722,92,1.08 [0.72-1.60],0.712298018403441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,35624,95,1.35 [0.90-2.04],0.1473849638251532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,40296,112,0.94 [0.73-1.22],0.6574396939586542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,41034,110,0.83 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,34583,90,0.88 [0.55-1.40],0.5882342689538309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,34553,90,1.05 [0.71-1.57],0.8065100494859959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,34912,91,1.10 [0.89-1.37],0.3884375538276375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,41125,113,0.78 [0.56-1.08],0.1300479053485795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,40101,112,0.76 [0.53-1.08],0.1270581775538325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,34553,90,0.97 [0.65-1.46],0.8955206409809361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,34722,92,0.93 [0.79-1.11],0.4283477190656883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,40541,108,0.73 [0.57-0.95],0.0195538386255367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,35515,96,0.87 [0.61-1.26],0.4759281749270326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,34580,90,0.84 [0.57-1.24],0.3698917738068218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,34669,94,0.81 [0.56-1.16],0.2507469033372141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,34912,91,1.10 [0.43-2.85],0.844056814069623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,40101,112,0.99 [0.72-1.35],0.9465175085688672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,35458,95,0.84 [0.53-1.31],0.4371298276924049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,35607,94,0.90 [0.49-1.64],0.726290897221454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",35624,95,0.95 [0.63-1.43],0.7993440912059777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,41140,112,1.40 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,40296,112,0.96 [0.69-1.33],0.7895633819779478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,41179,112,1.26 [0.71-2.25],0.4302394282259575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,41034,110,0.74 [0.40-1.35],0.3282043834392539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,41391,112,1.43 [0.66-3.10],0.3646060430596368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,40917,113,1.00 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,41192,113,0.92 [0.78-1.07],0.2800908579307271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,40296,112,0.89 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,40925,112,0.78 [0.49-1.23],0.2816496623233233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35524,95,0.80 [0.45-1.45],0.4655676558674663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,41402,112,1.06 [0.58-1.96],0.8457389157531381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,40075,112,0.88 [0.66-1.17],0.3858944624065408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,35515,96,0.96 [0.70-1.33],0.8153559369022056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,34583,90,0.77 [0.43-1.38],0.3841893809570439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,35524,95,0.90 [0.72-1.13],0.3629753951787251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",40101,112,0.97 [0.77-1.22],0.7945841842672932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,34553,90,1.15 [0.71-1.87],0.5576884322669018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,34553,90,0.73 [0.52-1.03],0.0770969443936507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,34646,90,1.18 [0.66-2.11],0.5693985201830627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,41140,112,1.14 [0.66-1.96],0.6385118620163672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,34646,90,1.14 [0.74-1.74],0.5528780047560135
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,34646,90,1.22 [0.72-2.06],0.4623263975084883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,39944,112,1.25 [0.86-1.82],0.2428088578454671
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,35024,96,1.05 [0.82-1.34],0.6878156748184507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,41140,112,0.89 [0.59-1.33],0.5749442339343454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,41192,113,0.77 [0.42-1.39],0.3789918037878873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,35515,96,0.95 [0.79-1.14],0.5742040051054402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,35624,95,1.08 [0.45-2.57],0.8636867779730854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,35700,95,0.97 [0.73-1.29],0.8375008678588151
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,41497,113,1.17 [0.64-2.14],0.6184781122466831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,34646,90,0.93 [0.73-1.19],0.5584232730874636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40984,113,0.89 [0.75-1.06],0.1811545978870669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40296,112,1.02 [0.78-1.35],0.8605004558291884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,34734,94,0.92 [0.70-1.21],0.5439938278168239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,35624,95,0.99 [0.63-1.56],0.9648454268994336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,34553,90,0.92 [0.70-1.22],0.5721860451747927
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,35024,96,0.84 [0.55-1.29],0.4286317787606619
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,40101,112,0.85 [0.59-1.22],0.3858609976387287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",35524,95,0.90 [0.74-1.09],0.2761546481806362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,34553,90,0.98 [0.72-1.32],0.8720352230887601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,34553,90,1.14 [0.72-1.82],0.5764792057742284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,40726,108,1.13 [0.29-4.46],0.8577484832644972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,35675,94,1.21 [0.66-2.22],0.5410314294180572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,35607,94,0.69 [0.26-1.82],0.4566502886823175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,34067,90,0.71 [0.37-1.35],0.2967914081581234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,41047,111,0.75 [0.48-1.18],0.2150871244646988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,41034,110,0.70 [0.55-0.88],0.0025850049588713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,40101,112,0.90 [0.65-1.25],0.5161671924615882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,34734,94,0.88 [0.58-1.32],0.5296990574047393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,35546,94,0.95 [0.73-1.24],0.7236331819201558
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,34722,92,0.96 [0.71-1.30],0.7886428940398754
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,34583,90,0.78 [0.48-1.28],0.3298218545493065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,34646,90,1.17 [0.47-2.93],0.7388860101736248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,41065,113,0.86 [0.41-1.80],0.6945146864410336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,35378,96,0.80 [0.60-1.06],0.1197653126730796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40726,108,1.21 [1.00-1.46],0.0468554334403248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,34431,93,0.60 [0.31-1.14],0.1155057170975695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,35624,95,0.76 [0.54-1.07],0.1122314346160227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,41034,110,1.02 [0.51-2.05],0.9512537009619694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,34553,90,1.04 [0.88-1.24],0.6105190319988651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",40075,112,1.27 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",34553,90,1.15 [0.71-1.86],0.5739717659540826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",40075,112,0.70 [0.49-1.00],0.0519365649710272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41529,114,0.92 [0.32-2.68],0.8819822257758607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,35680,94,0.86 [0.32-2.31],0.7678036074985624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,41529,114,1.04 [0.62-1.76],0.8825325101216966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35083,93,1.61 [0.96-2.72],0.0736853132042513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,34646,90,0.77 [0.41-1.45],0.4216563149398263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,34646,90,1.14 [0.96-1.35],0.1243958748053597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,35675,94,0.73 [0.46-1.14],0.1666464451683524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,40303,112,0.92 [0.82-1.03],0.1626524840939966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,40984,113,1.04 [0.72-1.51],0.8243625669025173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,34553,90,0.99 [0.61-1.62],0.9757461993688789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,40101,112,1.07 [0.89-1.30],0.4531859810409383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,41034,110,0.68 [0.44-1.05],0.0845749141723694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,35680,94,0.60 [0.33-1.10],0.097326280372706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,41028,112,1.29 [1.02-1.65],0.0359048740014925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,41402,112,0.95 [0.74-1.22],0.7089097458574136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,35700,95,0.91 [0.73-1.12],0.3690485578396291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,35624,95,1.41 [0.99-2.02],0.0598172358735548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,41255,112,1.17 [0.64-2.13],0.6134282478082933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41034,110,1.16 [0.65-2.08],0.6130052728050237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,40296,112,1.00 [0.71-1.39],0.980468064135098
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,34722,92,0.90 [0.50-1.63],0.7382315004354352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,41391,112,1.03 [0.80-1.33],0.7959879549928505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",35675,94,0.97 [0.74-1.27],0.8189053074505688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,35607,94,0.76 [0.38-1.52],0.441728822920871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,40917,113,1.00 [0.83-1.21],0.9929624371047482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,41140,112,0.78 [0.63-0.97],0.0266569405672198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,40984,113,0.96 [0.60-1.54],0.8720494778769455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,40101,112,1.01 [0.65-1.55],0.9790391447874864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,41391,112,1.92 [0.89-4.15],0.096115985069487
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,40984,113,0.94 [0.77-1.15],0.5325387002862958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,35515,96,0.99 [0.82-1.20],0.9403208191567496
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,41332,111,0.87 [0.55-1.38],0.5655157722884625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,41497,113,0.89 [0.69-1.16],0.3904656920543191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,34734,94,0.79 [0.34-1.86],0.5948967475353866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,34553,90,0.74 [0.46-1.18],0.207064428385311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,35463,95,0.84 [0.67-1.06],0.1427996473812547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40836,112,0.85 [0.63-1.15],0.2930951338516827
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,41034,110,1.00 [0.72-1.39],0.9933305921492988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,34646,90,0.97 [0.76-1.24],0.8082446349716816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,34553,90,0.78 [0.39-1.58],0.4943723254251733
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,34553,90,1.03 [0.58-1.84],0.9082353409381004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,40075,112,1.05 [0.68-1.62],0.838044993244332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,34646,90,1.05 [0.53-2.06],0.8927707803396806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,40597,108,0.89 [0.72-1.10],0.2852755441638674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35624,95,1.27 [0.82-1.96],0.2841965158652509
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,40015,112,0.96 [0.70-1.32],0.7964189586731317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,35024,96,0.97 [0.72-1.32],0.8621407467757612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,35524,95,0.87 [0.66-1.15],0.3317298087637008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,40836,112,0.85 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,41034,110,1.41 [0.97-2.06],0.0753961341598917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,35024,96,0.87 [0.62-1.22],0.4276108667147388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,33596,86,1.01 [0.85-1.20],0.8904018129956673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,41192,113,1.03 [0.69-1.52],0.8996751140074971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,40836,112,1.05 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,34583,90,1.07 [0.73-1.58],0.7321588381447808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,35607,94,0.93 [0.78-1.12],0.4606579092813753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,34734,94,0.90 [0.67-1.21],0.4939207807481081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,40836,112,1.05 [0.73-1.51],0.7815728277929279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,35598,93,0.99 [0.36-2.70],0.9871299633801872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,35607,94,0.91 [0.53-1.54],0.7230356216527094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,41065,113,0.72 [0.45-1.18],0.1942321286950185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,41255,112,1.23 [0.62-2.42],0.5540436472651232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,34722,92,1.12 [0.72-1.76],0.6127941312453867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,34583,90,1.08 [0.76-1.54],0.6602086272792406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,35524,95,0.81 [0.58-1.14],0.2292161467571583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,35624,95,0.88 [0.64-1.21],0.4280752315429277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",34734,94,0.79 [0.59-1.07],0.1292307257768687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,41391,112,1.00 [0.90-1.12],0.9822741195710124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,40813,111,0.85 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,34553,90,0.92 [0.65-1.28],0.605888584488631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,40296,112,1.06 [0.81-1.39],0.6804455662574953
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,40015,112,1.14 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,40726,108,1.05 [0.92-1.20],0.4970362809471084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,35624,95,0.98 [0.83-1.16],0.8120855048617699
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",35024,96,0.86 [0.57-1.30],0.4851832910244188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40303,112,0.84 [0.61-1.14],0.2554310228995007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,34734,94,0.76 [0.46-1.25],0.2776421760433983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,34366,93,1.06 [0.74-1.53],0.7472866265294063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,40075,112,0.81 [0.60-1.09],0.1726633510302632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,34646,90,1.06 [0.65-1.74],0.8104805754083698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,35324,95,0.83 [0.43-1.60],0.5789371562379324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35607,94,0.99 [0.58-1.70],0.9749379159284532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,34553,90,1.01 [0.78-1.30],0.9589951448816332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,41318,113,0.68 [0.39-1.16],0.1584326523277414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,41034,110,1.10 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,40296,112,0.59 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,35024,96,0.71 [0.52-0.97],0.0322994525018679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,41034,110,1.07 [0.77-1.47],0.6953935062400501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,40984,113,1.05 [0.79-1.40],0.7212274435322916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,34912,91,0.83 [0.53-1.31],0.428578808393483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,34431,93,1.39 [0.73-2.63],0.3125807814824551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,40075,112,0.80 [0.57-1.14],0.2135752778236183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,35524,95,1.04 [0.55-1.98],0.902335739937842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,34583,90,1.03 [0.82-1.30],0.7770082196766318
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,34838,91,1.06 [0.68-1.65],0.7921647065943886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,35624,95,0.86 [0.66-1.14],0.2997129947890282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,41362,113,0.59 [0.25-1.39],0.2258453184422135
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,35624,95,0.96 [0.44-2.07],0.91466268452079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,35524,95,0.83 [0.45-1.54],0.563091943916895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,35524,95,1.07 [0.59-1.93],0.829409526279998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,35515,96,1.40 [0.89-2.18],0.1414539011933017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,34431,93,0.77 [0.52-1.15],0.208597566889663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,35515,96,1.18 [0.80-1.75],0.4102053351511661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,41529,114,1.11 [0.73-1.68],0.6362202381629583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,35524,95,0.99 [0.77-1.28],0.9466374295726508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,35675,94,0.90 [0.73-1.10],0.2915157382013528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41338,112,1.36 [0.95-1.96],0.0934471550509556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,40836,112,0.93 [0.54-1.59],0.7867096358334774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,41391,112,1.05 [0.79-1.39],0.742286994782984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,34431,93,1.00 [0.69-1.46],0.9808864430636696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",34431,93,0.74 [0.46-1.18],0.20077220990705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",34553,90,1.23 [0.94-1.59],0.1260150213639506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",34912,91,0.95 [0.78-1.15],0.6061377197291613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,41529,114,0.83 [0.66-1.03],0.0965285736313358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,41192,113,0.84 [0.69-1.01],0.0633359847221269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,40101,112,0.63 [0.49-0.81],0.0004313847627386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,41529,114,0.81 [0.53-1.24],0.3264244613154441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,34431,93,0.87 [0.51-1.47],0.5969082935375375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,34912,91,0.84 [0.36-1.95],0.6892822904213676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,35680,94,0.82 [0.59-1.15],0.2484598452093515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,34431,93,1.12 [0.82-1.52],0.4724679534064802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,35624,95,1.01 [0.86-1.19],0.9080417657366526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,41192,113,0.97 [0.85-1.10],0.6002415034784054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",40101,112,0.71 [0.48-1.06],0.0949026658666791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,34722,92,1.08 [0.76-1.53],0.6600627903054045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34431,93,1.19 [0.91-1.56],0.2111622240074612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,34553,90,0.85 [0.59-1.23],0.3822431807047902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34646,90,1.25 [0.82-1.89],0.2952480018461094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,41529,114,0.81 [0.38-1.74],0.5956717954840383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,41034,110,1.00 [0.74-1.35],0.9878329272987868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,41034,110,0.72 [0.41-1.27],0.2564420252131372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,34734,94,0.66 [0.31-1.43],0.2954584481119016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,34912,91,1.36 [0.74-2.50],0.320762086206478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,35700,95,1.47 [0.70-3.11],0.31286115555904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,34646,90,0.87 [0.73-1.04],0.1221438244107946
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,35462,92,0.83 [0.68-1.03],0.0858511399087751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,40075,112,0.99 [0.73-1.34],0.9642500774949632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,34431,93,0.64 [0.41-1.00],0.0511493328119297
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,34722,92,1.10 [0.84-1.44],0.5016692773903777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,35700,95,1.22 [0.92-1.62],0.1626156688193719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",35675,94,1.05 [0.73-1.51],0.7980233228762572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41497,113,1.39 [0.77-2.50],0.2705238885736714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,41331,113,1.20 [0.83-1.75],0.3293260088321375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35272,92,0.73 [0.39-1.40],0.3468267690506492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,34553,90,0.92 [0.64-1.31],0.633910327049908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,34722,92,0.65 [0.41-1.03],0.0685873413560114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,34646,90,0.87 [0.69-1.10],0.2543575705736279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,35624,95,0.92 [0.77-1.09],0.3366314780567017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,35524,95,0.82 [0.56-1.20],0.3073704519958108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,34431,93,1.11 [0.92-1.34],0.2745828915915719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40726,108,0.62 [0.37-1.04],0.0723690272003998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,34912,91,0.77 [0.47-1.24],0.2783170605049443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,35700,95,1.33 [0.60-2.97],0.4849187998203084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PI3,Elafin,40490,110,0.96 [0.70-1.30],0.7715129366670004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",35624,95,0.95 [0.73-1.22],0.6738129234226293
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,40520,109,0.74 [0.46-1.21],0.2267724732531679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40984,113,1.02 [0.78-1.34],0.8762955261456337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41034,110,1.59 [0.88-2.87],0.1205188727790576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,34646,90,0.96 [0.66-1.39],0.8204165928718166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,41034,110,0.83 [0.57-1.21],0.3338975415903097
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,41028,112,0.82 [0.62-1.07],0.1436849390877455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,34912,91,0.83 [0.63-1.10],0.2022003244744886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,34366,93,0.98 [0.76-1.26],0.8730201043673673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,35675,94,1.32 [0.62-2.79],0.4751609972592879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,34553,90,0.78 [0.54-1.14],0.1984120126234118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,41064,113,1.24 [0.98-1.57],0.0711505983314071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,35024,96,0.84 [0.64-1.11],0.2118428556239654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,40726,108,0.95 [0.71-1.26],0.7236272496398419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41140,112,0.83 [0.43-1.57],0.5607724353953457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,41466,114,0.97 [0.66-1.44],0.8894243170742735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",40940,113,1.06 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,41192,113,0.91 [0.75-1.10],0.3186034420573073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,41034,110,1.37 [0.78-2.40],0.2721138292324144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,41401,114,1.06 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41034,110,0.95 [0.53-1.72],0.8642267569810081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40736,111,0.74 [0.40-1.40],0.3588864231132607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",35607,94,1.03 [0.74-1.43],0.8693577343282431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",34646,90,0.89 [0.55-1.44],0.629605345200737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",35607,94,0.97 [0.80-1.19],0.7969640877300479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,35607,94,0.87 [0.65-1.17],0.356610275072114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,34814,90,0.84 [0.34-2.08],0.6987058529528749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,40075,112,0.91 [0.54-1.53],0.7276800207493491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,35549,94,0.76 [0.54-1.08],0.1237399951889136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,41383,113,1.11 [0.69-1.78],0.6776743426783052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,40101,112,1.03 [0.64-1.67],0.8945512140227398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,35607,94,0.87 [0.41-1.83],0.7084472762523004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,40984,113,0.83 [0.68-1.02],0.0762268482558187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41344,113,0.70 [0.34-1.44],0.3270808180893724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40847,112,1.00 [0.91-1.10],0.9642173057455824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,34553,90,1.03 [0.82-1.30],0.8030850401232206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,34553,90,0.76 [0.54-1.08],0.1270356480988465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,34722,92,0.98 [0.66-1.46],0.9105485530789847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,40008,112,1.00 [0.85-1.16],0.952761964082808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,35700,95,0.93 [0.68-1.29],0.6767748783677565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,35607,94,1.05 [0.81-1.35],0.7283547694394367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,40992,112,1.02 [0.96-1.08],0.4666113397515279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,34734,94,0.77 [0.53-1.11],0.1628471372246986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,34583,90,0.78 [0.48-1.27],0.3227411215212642
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40296,112,1.02 [0.85-1.22],0.8361515506089934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,40836,112,1.67 [0.55-5.05],0.3605991940284193
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,41140,112,1.38 [0.76-2.53],0.291999117730663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34646,90,1.01 [0.65-1.58],0.9577017064663612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,34646,90,1.08 [0.56-2.10],0.8159329569841767
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40836,112,1.08 [0.83-1.41],0.577119125914563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,34734,94,0.99 [0.74-1.32],0.9281097400351777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,35700,95,0.92 [0.44-1.94],0.8293041753096638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,40303,112,0.81 [0.52-1.27],0.3597263757436736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,41192,113,0.62 [0.37-1.07],0.0857612644467014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,35680,94,0.97 [0.57-1.65],0.9061892227840954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,35457,92,0.85 [0.67-1.08],0.1809035491065713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,41391,112,0.88 [0.61-1.26],0.4767009763064578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,35024,96,1.10 [0.83-1.46],0.4873724189116233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",35680,94,0.83 [0.59-1.16],0.2775055267594198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,34646,90,0.57 [0.29-1.13],0.1077004882261622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,40101,112,0.82 [0.46-1.45],0.4939396115050577
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,34646,90,0.83 [0.57-1.21],0.3276527255640791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,35675,94,0.81 [0.55-1.18],0.2657793080403915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,40836,112,1.15 [0.88-1.52],0.311235837893194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,35515,96,0.91 [0.72-1.16],0.4379193180624998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41140,112,0.92 [0.77-1.11],0.3948100754428503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,35024,96,1.00 [0.77-1.31],0.9765075188901624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,35624,95,0.77 [0.59-1.00],0.0505846798515901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,35624,95,1.17 [0.73-1.89],0.5090411474535541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,41497,113,0.98 [0.83-1.17],0.8648536534958584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,35524,95,0.98 [0.83-1.16],0.8294669362094012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,40726,108,0.81 [0.49-1.34],0.4192446156280691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,34722,92,0.88 [0.65-1.18],0.3858957560609799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,40949,112,0.98 [0.84-1.16],0.85050076212008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,40101,112,1.03 [0.78-1.37],0.813311686590126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,34431,93,0.73 [0.33-1.63],0.4382058960905247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,35680,94,0.71 [0.44-1.14],0.1601709264106254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,35515,96,1.43 [1.16-1.77],0.000785581820367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41280,114,1.07 [0.52-2.18],0.8573723195082659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,39886,105,0.98 [0.80-1.19],0.8274958428458425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,35098,92,1.21 [0.89-1.65],0.2143935413556695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40296,112,0.85 [0.67-1.08],0.1902544808230668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",41497,113,0.97 [0.76-1.24],0.80566134049854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,41402,112,0.94 [0.71-1.24],0.6680493841967334
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,40296,112,0.85 [0.47-1.54],0.5866744962362151
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,40992,112,1.44 [0.81-2.56],0.2146804052136152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,35680,94,0.90 [0.61-1.32],0.5785486532010893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,35680,94,0.68 [0.46-1.02],0.0645142610048742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40296,112,0.97 [0.71-1.33],0.8606598492185454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,34722,92,0.76 [0.39-1.49],0.4294371273477004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,35537,94,1.00 [0.78-1.27],0.9786597575750414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,40296,112,0.69 [0.44-1.07],0.0961589274475373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,34553,90,0.88 [0.54-1.42],0.5909506979641217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,34912,91,1.00 [0.85-1.18],0.9781844689640444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,40101,112,0.89 [0.69-1.15],0.3573559453276943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,41391,112,0.90 [0.71-1.13],0.3523040693005985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,35607,94,0.76 [0.51-1.15],0.192848545300368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,41120,112,1.49 [0.76-2.95],0.2477873197636191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,34553,90,1.09 [0.65-1.83],0.7449487352835593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,40984,113,0.70 [0.51-0.95],0.0216037214663442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,35728,94,1.41 [0.67-2.98],0.3670399409590731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,34662,89,0.81 [0.59-1.11],0.191864485649517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,34646,90,0.79 [0.49-1.28],0.3372572443082721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,34734,94,1.50 [0.89-2.52],0.129875285181464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,41179,112,0.87 [0.63-1.21],0.4195748301280965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,34646,90,1.01 [0.56-1.81],0.9709980030351264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,35607,94,0.74 [0.43-1.27],0.2751994152056259
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,40075,112,0.97 [0.84-1.13],0.7303215790968294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,41402,112,1.72 [0.91-3.26],0.0951525978350817
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,35024,96,0.93 [0.47-1.85],0.8386393546329955
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,35351,93,0.98 [0.48-1.98],0.954445212376151
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,35524,95,0.87 [0.59-1.30],0.5034948160714752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,35524,95,1.02 [0.94-1.10],0.6191117575064422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,40726,108,1.04 [0.90-1.21],0.5820914869820156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,40984,113,0.87 [0.66-1.16],0.3527923259709059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,40101,112,1.06 [0.62-1.80],0.8409244896937605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,34431,93,0.94 [0.49-1.80],0.8452778444144201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,35624,95,1.10 [0.75-1.61],0.6356921976423041
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,34722,92,1.06 [0.76-1.49],0.7165578340768902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,40836,112,1.24 [0.91-1.69],0.1705221154635673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,40666,108,0.98 [0.62-1.54],0.9192730525127544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,40538,107,1.04 [0.65-1.65],0.8824867243413766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,40984,113,1.31 [0.96-1.79],0.0937255840399115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,34646,90,1.37 [1.01-1.86],0.043158930187961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,40984,113,1.13 [0.96-1.33],0.1466845181274869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,40101,112,0.79 [0.58-1.08],0.1359450031204514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,33667,87,0.95 [0.79-1.15],0.6178221012680722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",40075,112,0.86 [0.49-1.50],0.5951758733680098
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,40723,111,1.39 [0.80-2.40],0.237283581653541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,34383,90,0.94 [0.65-1.38],0.7665648684339221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,35675,94,1.09 [0.86-1.39],0.4808863928293556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,34722,92,1.04 [0.81-1.35],0.745958025781625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40984,113,1.14 [0.77-1.68],0.5097376832335574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,40075,112,1.00 [0.64-1.57],0.9912398347886162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,40303,112,1.10 [0.76-1.60],0.6038528478597469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,34646,90,1.13 [0.79-1.62],0.5065763079187799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40726,108,0.98 [0.79-1.22],0.8466199789998488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41132,113,0.95 [0.79-1.14],0.5639850362430269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,34581,89,1.26 [0.80-1.98],0.3203280442152488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,35675,94,0.83 [0.42-1.65],0.6033691701499224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,35680,94,0.66 [0.27-1.62],0.3654540693668625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,41529,114,0.97 [0.56-1.68],0.9093637969740448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,35524,95,0.99 [0.66-1.49],0.9709546266516542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35524,95,0.64 [0.24-1.71],0.3713633081228775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,40915,113,0.63 [0.32-1.26],0.1932283639191271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40586,108,1.29 [0.76-2.17],0.3454398339600969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,35607,94,1.39 [0.82-2.33],0.219886845054398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,41529,114,1.14 [0.58-2.24],0.7086014685898367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35675,94,0.74 [0.40-1.37],0.3408440003276802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,34912,91,0.91 [0.65-1.27],0.5706112750275114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,39891,111,1.14 [0.93-1.38],0.2050384084467477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,35024,96,1.03 [0.64-1.66],0.8889824317047652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,40984,113,0.99 [0.71-1.36],0.9282031426223616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,41214,111,1.05 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,41391,112,0.99 [0.62-1.58],0.961586702370602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,35515,96,0.66 [0.41-1.06],0.0870845312333096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,40075,112,0.89 [0.63-1.26],0.5148442550368915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,34734,94,1.43 [0.97-2.09],0.0687448947214057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,34553,90,0.96 [0.78-1.19],0.7427196871599654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,35728,94,1.07 [0.75-1.53],0.7204945759130414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,41085,114,0.81 [0.44-1.50],0.4962835913243858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,34998,87,0.84 [0.46-1.52],0.5597628638287957
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,35675,94,0.83 [0.57-1.21],0.3388321430381333
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,35675,94,0.97 [0.81-1.16],0.7413887214204038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,35675,94,0.96 [0.76-1.21],0.7226196214563589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,35515,96,0.83 [0.60-1.15],0.2689984751851073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,34553,90,0.96 [0.70-1.31],0.7873267110864025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,40296,112,0.96 [0.77-1.18],0.6866830234177806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,34553,90,0.87 [0.66-1.15],0.3165760846110731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,34583,90,0.90 [0.61-1.32],0.5842224376829949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,35515,96,1.34 [1.00-1.79],0.0463326111418692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,40984,113,1.16 [0.81-1.65],0.4171245424245422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,40075,112,0.75 [0.51-1.11],0.1450757986731183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,34912,91,0.89 [0.68-1.16],0.3813826234606633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,40101,112,0.81 [0.58-1.11],0.1863640533576882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,40296,112,0.93 [0.70-1.23],0.5998971740105858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,34722,92,1.22 [0.98-1.52],0.070819486200325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,40101,112,0.97 [0.68-1.39],0.8747925917260081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,35024,96,0.91 [0.62-1.35],0.6531448360172937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,34646,90,1.30 [0.69-2.44],0.4178255188159043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,35515,96,1.35 [1.01-1.81],0.0449764498045141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,34734,94,1.01 [0.70-1.47],0.9506329999404516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,34583,90,0.91 [0.49-1.69],0.7760655492066801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,40101,112,0.85 [0.58-1.23],0.3806898660339384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,34646,90,1.07 [0.82-1.40],0.6338314835373284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,35024,96,0.72 [0.48-1.08],0.1140775476531139
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,40101,112,0.59 [0.32-1.10],0.0993043202675127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,41255,112,0.83 [0.61-1.14],0.257588041619024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,40075,112,0.86 [0.51-1.45],0.5827822368728801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,34431,93,1.17 [0.76-1.81],0.4844576564144448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,40101,112,0.84 [0.59-1.18],0.3120775213254366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35624,95,1.38 [0.89-2.15],0.145476039141611
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,40067,108,1.23 [0.90-1.69],0.1864207452925571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,35624,95,0.90 [0.69-1.17],0.4193296581432887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,34553,90,0.91 [0.58-1.44],0.6983536571342236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,34431,93,0.79 [0.50-1.23],0.2949067117594554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,34722,92,0.79 [0.55-1.12],0.1891000679192804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,40836,112,1.08 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,40836,112,1.00 [0.74-1.36],0.9750984456733066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,35524,95,1.04 [0.76-1.42],0.8107492435913247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,34646,90,1.02 [0.76-1.37],0.8822730186359264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,34734,94,0.92 [0.76-1.12],0.4132274883620846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,35515,96,1.11 [0.79-1.56],0.5436224781186564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,40303,112,0.90 [0.56-1.45],0.6575719383346724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,34734,94,0.84 [0.32-2.21],0.7224581205471605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,35624,95,0.77 [0.54-1.09],0.1376484169427188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,40783,111,1.08 [0.77-1.52],0.66182293909769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,41529,114,0.99 [0.84-1.16],0.8910736115724806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,41529,114,1.07 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,35515,96,0.54 [0.32-0.92],0.0239145989669341
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,41065,113,1.08 [0.77-1.52],0.6603980835274369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,34646,90,0.73 [0.45-1.18],0.1948724036957576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,41034,110,1.11 [0.48-2.56],0.8028390213985467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,34646,90,0.90 [0.52-1.56],0.7144092890017117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,34431,93,1.28 [0.78-2.09],0.3231536745029854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40836,112,1.13 [0.73-1.73],0.586113634552736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RETN,Resistin,40929,113,1.15 [0.78-1.69],0.4768614389099532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",34553,90,0.91 [0.58-1.41],0.6607099978605169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,35515,96,1.20 [0.50-2.89],0.6810468723609457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,35624,95,0.85 [0.65-1.09],0.2026812820932736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,35024,96,0.84 [0.59-1.19],0.3298019629405323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,41391,112,1.18 [0.70-2.01],0.532512817809942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,41391,112,1.23 [0.61-2.51],0.5604231255978422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,35624,95,0.92 [0.66-1.29],0.6374121430148281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,40296,112,0.92 [0.70-1.19],0.5202113173850258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,40475,108,0.95 [0.83-1.10],0.5050211828074406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,34646,90,0.88 [0.56-1.40],0.5971170658814915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,34912,91,1.12 [0.75-1.68],0.5806767851159468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,41280,111,1.04 [0.79-1.38],0.7692776168037557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,35675,94,0.92 [0.76-1.13],0.4312282724757257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34553,90,0.76 [0.52-1.10],0.1481975116879194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,35624,95,0.67 [0.40-1.12],0.1274761365416598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,34852,91,0.88 [0.69-1.13],0.3092180924481574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,35700,95,1.23 [0.57-2.63],0.6008719956087624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,34734,94,1.11 [0.74-1.66],0.6055157668965866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,40837,112,1.17 [1.10-1.25],1.4979406001024344e-06
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,34526,91,1.67 [0.87-3.21],0.1239635321942795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35438,95,0.95 [0.49-1.85],0.8840283328545169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,35624,95,1.13 [0.79-1.59],0.5058607294203497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41344,114,1.24 [0.67-2.31],0.4883888765951538
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34734,94,1.23 [0.65-2.34],0.5182355726719341
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,34646,90,0.86 [0.51-1.44],0.5580052254238819
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,34646,90,1.16 [0.72-1.87],0.5516172067911085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,35024,96,1.02 [0.77-1.35],0.902227269811644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,40101,112,0.97 [0.75-1.25],0.7980459477023214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,35024,96,1.18 [0.89-1.57],0.2460206732648251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,34734,94,0.96 [0.73-1.25],0.7399628208939928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41065,113,0.69 [0.33-1.44],0.321748573593734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,41391,112,0.95 [0.46-1.96],0.8809720754066217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,34734,94,1.48 [0.48-4.52],0.4907101438134673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41028,112,1.38 [0.81-2.34],0.2318460093787003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,40836,112,0.86 [0.57-1.29],0.45701681867704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,34646,90,1.21 [0.66-2.22],0.5331426985270109
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,35024,96,0.96 [0.73-1.26],0.7521314627685658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,34722,92,1.14 [0.72-1.80],0.5722347681280917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,34734,94,0.92 [0.55-1.53],0.7542331250359843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,34553,90,0.78 [0.45-1.36],0.3871176601351964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,34722,92,0.90 [0.76-1.05],0.1905939043796973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,40101,112,0.62 [0.40-0.95],0.0283698370285518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,40101,112,0.89 [0.69-1.15],0.3821937896932107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,34583,90,0.99 [0.80-1.24],0.9586754767206744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,40726,108,0.91 [0.53-1.57],0.7342702181431847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,41402,112,1.59 [0.89-2.84],0.1139277866432907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,40836,112,1.33 [0.74-2.39],0.3393166127156442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,34553,90,0.82 [0.51-1.29],0.3853935824767353
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",35624,95,0.90 [0.72-1.12],0.3407047673160984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,41402,112,0.88 [0.55-1.39],0.5720145011706721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,40101,112,0.98 [0.83-1.15],0.781036503272136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,41391,112,0.95 [0.73-1.24],0.7040724149462534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,34553,90,0.77 [0.40-1.50],0.4479919892374066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,40712,111,1.18 [0.87-1.60],0.2920530921944161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,40454,110,1.05 [0.84-1.31],0.6771383271738507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,34646,90,0.62 [0.33-1.15],0.1298671451689844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,35624,95,1.12 [0.78-1.61],0.5381508816790874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,40015,112,1.04 [0.79-1.35],0.7944890655625891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,35515,96,1.28 [0.94-1.73],0.1207215657357346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,41140,112,0.92 [0.69-1.22],0.5551806828281954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,35624,95,0.95 [0.61-1.47],0.8024320875185086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,40303,112,1.21 [0.93-1.58],0.1573531331827167
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,35728,94,0.68 [0.25-1.81],0.4380657839143761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,35624,95,0.50 [0.22-1.10],0.0854062992935253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,34583,90,0.96 [0.65-1.42],0.8309865962169168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,40984,113,0.90 [0.71-1.14],0.3781892389920929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,35024,96,0.84 [0.62-1.14],0.2567313071339706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,35550,93,0.97 [0.81-1.16],0.7373148167467434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,34553,90,1.19 [0.75-1.87],0.464902847365619
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,34553,90,1.19 [0.84-1.68],0.3171475744000238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,35024,96,0.79 [0.56-1.10],0.155651719500332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,35624,95,0.90 [0.46-1.76],0.7543220532499989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,35612,94,0.78 [0.44-1.40],0.4052262527558518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,40836,112,0.95 [0.78-1.16],0.6234023297622382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,41391,112,0.96 [0.54-1.70],0.8905853547889421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,40075,112,1.25 [1.00-1.56],0.0531560027999143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,39952,106,0.95 [0.54-1.67],0.8639205229391769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,41529,114,0.73 [0.49-1.09],0.1255960187271241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41391,112,1.39 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,41210,110,0.87 [0.51-1.47],0.5958053196000415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,41065,113,1.13 [0.69-1.87],0.6241896408326918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,41066,113,1.29 [1.04-1.59],0.020082149113056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,34553,90,1.44 [0.88-2.36],0.1492947610737864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,34912,91,1.44 [0.66-3.15],0.3630307340553634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,41132,113,0.88 [0.70-1.10],0.268040407745519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,40296,112,1.22 [0.84-1.78],0.2894439100175163
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,34583,90,1.15 [0.90-1.47],0.2692217820056566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,41280,111,0.77 [0.53-1.12],0.1759823503455501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,34583,90,1.21 [0.84-1.74],0.2980655520383698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,34722,92,1.36 [0.73-2.52],0.3303800249059647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,34722,92,1.22 [0.76-1.94],0.4127757237200028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,34583,90,0.72 [0.43-1.20],0.2128413399041265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,34734,94,0.89 [0.55-1.43],0.6222144740608757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,40101,112,0.92 [0.73-1.17],0.5200730403167584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,34609,94,0.63 [0.41-0.97],0.0338422631099216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,35675,94,0.74 [0.35-1.57],0.4336193121204992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,34734,94,1.02 [0.82-1.26],0.8778706190373392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,40984,113,0.84 [0.62-1.15],0.277788673082915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCT,Secretin,34722,92,0.94 [0.60-1.46],0.7747619885691567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,41028,112,0.71 [0.50-1.03],0.069533110508945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,35515,96,1.01 [0.85-1.20],0.8894518682891793
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,35524,95,0.61 [0.43-0.88],0.008400445281457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,34912,91,0.96 [0.56-1.65],0.8796177036109583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,34734,94,0.97 [0.75-1.26],0.8318476400397964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,34734,94,1.23 [0.73-2.07],0.441246285083536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,41529,114,0.89 [0.64-1.23],0.4655197710472571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,35728,94,2.21 [1.06-4.62],0.035171915538844
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,35728,94,0.67 [0.28-1.59],0.3635537816166982
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,41179,112,0.91 [0.68-1.23],0.5468336061405605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,40984,113,0.68 [0.37-1.25],0.2125720869985752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,41028,112,1.51 [0.85-2.67],0.1618691035892069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,34912,91,1.03 [0.65-1.62],0.9113995686620804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,40836,112,0.94 [0.05-16.99],0.9690707441153652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,41391,112,0.69 [0.40-1.18],0.1771189846396577
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,34646,90,1.27 [0.64-2.50],0.4908578979548242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41401,114,1.23 [0.67-2.25],0.5032520793396426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,35624,95,1.16 [0.91-1.47],0.2396803012004098
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,35024,96,1.21 [0.90-1.62],0.2096319778103582
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,35534,94,0.99 [0.53-1.84],0.9727679294356004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,40836,112,0.62 [0.43-0.89],0.0103934741387446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,35046,92,1.91 [0.19-19.30],0.5840931813408186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,41529,114,0.99 [0.66-1.49],0.9700213317097172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,35603,92,0.55 [0.14-2.20],0.3952116878108239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,35062,93,0.77 [0.33-1.77],0.5408195265188809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,35189,94,1.12 [0.62-2.02],0.7056374081628571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,35728,94,0.46 [0.14-1.53],0.2036765488194184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,35728,94,2.10 [0.75-5.88],0.1574569641456267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40627,112,1.05 [0.89-1.24],0.5806974392631662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,40908,110,1.00 [0.81-1.22],0.9741036689466728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,40303,112,1.21 [0.85-1.71],0.2935816773031614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,41258,112,0.88 [0.66-1.17],0.3727092414274758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,41497,113,1.02 [0.81-1.29],0.8661942901358906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,40726,108,0.93 [0.56-1.54],0.7692934040716563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,35659,94,0.61 [0.16-2.30],0.4687548049797013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,35659,94,0.98 [0.48-1.99],0.9510212037902448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,41529,114,0.86 [0.69-1.08],0.1858190058686316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,35675,94,0.85 [0.62-1.16],0.3046527965952202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,35188,92,1.40 [0.66-2.97],0.3733888245397476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,35045,92,0.52 [0.12-2.23],0.3800903443222759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,35659,94,1.06 [0.37-3.05],0.9186699197361228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,35024,96,0.94 [0.81-1.10],0.4287839635534649
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,34842,91,0.63 [0.31-1.28],0.2050592560131628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,35524,95,0.89 [0.62-1.28],0.5288009550125283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,40075,112,0.91 [0.70-1.19],0.4967672218060497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,40597,108,0.72 [0.40-1.29],0.2729665548024099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,34722,92,1.23 [0.65-2.30],0.5255168346218337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,41140,112,1.65 [0.97-2.80],0.0630336432461466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,40836,112,1.70 [0.75-3.84],0.2053647986230607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,40836,112,0.99 [0.79-1.25],0.95749312257221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,40593,108,1.34 [0.82-2.19],0.241842016074243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,34912,91,1.01 [0.61-1.65],0.9837685804999812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,40101,112,0.92 [0.67-1.26],0.5907938191823356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,40101,112,0.85 [0.60-1.21],0.3717904564236372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,41028,112,0.82 [0.64-1.04],0.1002565185756741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,35075,94,0.68 [0.46-1.00],0.048705772639286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,40101,112,0.93 [0.78-1.10],0.3885338738925719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,40984,113,0.88 [0.65-1.19],0.4026523394063319
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,34583,90,0.91 [0.63-1.30],0.6008514541835421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,35524,95,0.95 [0.64-1.42],0.8020712395264555
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,34824,96,0.94 [0.75-1.18],0.5951205922339212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,35607,94,0.94 [0.70-1.26],0.6621372513747794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,35700,95,0.97 [0.66-1.43],0.8815639315706278
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,34431,93,1.06 [0.90-1.25],0.4799854058015792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,34486,90,1.13 [0.93-1.38],0.2013147069017891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,34646,90,0.99 [0.62-1.58],0.959801799676794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35680,94,1.22 [0.58-2.56],0.5998253795537727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",41132,113,0.98 [0.81-1.19],0.8701871150600631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,35024,96,1.12 [0.72-1.74],0.6071641627023991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,41075,112,0.85 [0.60-1.22],0.3880583452629018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41192,113,0.98 [0.67-1.44],0.918122919467914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,40984,113,0.74 [0.62-0.87],0.0002748760608176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,40075,112,0.97 [0.77-1.21],0.7791006161758028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,41034,110,1.09 [0.93-1.29],0.2822113446928397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41402,112,0.98 [0.59-1.63],0.9489034541531508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,41028,112,1.43 [0.79-2.58],0.2353686995233765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34734,94,0.97 [0.62-1.51],0.8786905807902445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,41342,111,0.67 [0.38-1.16],0.1501330133628148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,34734,94,1.40 [0.90-2.19],0.1354182966690673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41127,112,0.87 [0.63-1.20],0.3972915603062297
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,34646,90,0.88 [0.68-1.15],0.3548053995695723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,40836,112,0.94 [0.78-1.14],0.5308080373500783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",40075,112,0.92 [0.67-1.27],0.6015187801207178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,40296,112,0.73 [0.60-0.90],0.0024340903450274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,40650,108,0.85 [0.67-1.07],0.1639446983569012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,41192,113,0.92 [0.78-1.08],0.3007602109559654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,34553,90,0.80 [0.45-1.40],0.4273616557047772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,35624,95,0.89 [0.74-1.08],0.232587655640623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,40296,112,0.97 [0.73-1.30],0.8475130878444929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,40101,112,0.96 [0.52-1.77],0.890651199291669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,40984,113,0.93 [0.69-1.24],0.600161927881784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40101,112,0.98 [0.72-1.35],0.913216988779885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,34553,90,0.87 [0.40-1.90],0.7224254126466542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,35515,96,1.05 [0.78-1.42],0.757796858070926
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,40075,112,1.03 [0.78-1.36],0.8522742818320042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,34722,92,1.04 [0.72-1.51],0.8168300000580726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,40075,112,0.77 [0.58-1.03],0.0804425081014163
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,34431,93,0.79 [0.54-1.17],0.2438386814332589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,34431,93,1.08 [0.74-1.59],0.6890976426009268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,40075,112,1.18 [0.74-1.89],0.4836928152446313
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,40984,113,0.73 [0.54-1.00],0.0512455514065073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,34722,92,1.04 [0.79-1.37],0.7836095551327362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,35680,94,0.99 [0.66-1.50],0.9653213072812024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,34553,90,1.09 [0.84-1.40],0.5213065791014622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,34912,91,0.87 [0.69-1.11],0.2685412332220018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,35524,95,0.76 [0.47-1.22],0.252311167136227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",34431,93,1.14 [0.83-1.56],0.426257036634138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,40075,112,0.82 [0.65-1.02],0.0757238284554753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,34646,90,1.44 [0.77-2.68],0.2540972701398508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,41402,112,0.80 [0.52-1.23],0.3122598628042234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,40303,112,1.17 [0.73-1.87],0.5169060303565813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,35024,96,1.08 [0.87-1.35],0.4717008268938454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,35524,95,0.90 [0.70-1.15],0.3979973206096415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,35413,94,0.99 [0.58-1.68],0.9730515161092084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,40101,112,0.90 [0.73-1.11],0.327334552759889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,35515,96,0.86 [0.64-1.16],0.3295168783490402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,35515,96,0.79 [0.53-1.17],0.24325346921003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,40836,112,0.80 [0.34-1.91],0.6172332373938005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,40075,112,0.77 [0.60-1.00],0.0466066305742479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,34431,93,0.73 [0.47-1.12],0.1520955441955186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,35524,95,1.08 [0.81-1.45],0.5857375071107949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,41402,112,1.13 [0.66-1.94],0.6431879158562316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,41192,113,0.88 [0.58-1.32],0.5299420226970036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,41185,112,0.67 [0.51-0.89],0.0050438193569534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,34646,90,1.03 [0.74-1.42],0.8689422010440788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41124,113,0.86 [0.67-1.10],0.2169801093881884
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,35515,96,1.16 [0.95-1.43],0.1438591260204649
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,34583,90,0.76 [0.53-1.10],0.1514857272996402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,35543,94,0.98 [0.80-1.22],0.8792381227318696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,34583,90,0.92 [0.59-1.42],0.7073875485819929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,41140,112,0.91 [0.76-1.09],0.2863190228896692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,35624,95,1.02 [0.72-1.43],0.928283205205528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,34912,91,1.02 [0.86-1.22],0.8123138860996459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,40726,108,0.87 [0.71-1.08],0.2059664290585352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",34734,94,1.05 [0.58-1.91],0.8791496917128686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',35607,94,1.27 [0.95-1.71],0.1092361233860036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,34553,90,1.19 [0.92-1.54],0.1887292606302678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,34912,91,1.06 [0.73-1.53],0.7575501041122278
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,35524,95,0.90 [0.56-1.43],0.6539027075775201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,35515,96,0.90 [0.70-1.16],0.4098603191113837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,34734,94,0.68 [0.34-1.39],0.2956689812945663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],40204,109,1.17 [0.83-1.65],0.3590087909009616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",41034,110,0.88 [0.55-1.41],0.6086011720449545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,35700,95,0.90 [0.61-1.31],0.5752918597612624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,35624,95,1.26 [0.85-1.88],0.2487897212502913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,40101,112,1.26 [0.78-2.04],0.3471726044617379
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,41210,111,1.11 [0.86-1.42],0.4202248728317074
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,40974,112,0.75 [0.45-1.24],0.257224938820209
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,40974,112,1.20 [0.80-1.78],0.3760487095026287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,34722,92,1.08 [0.74-1.57],0.6811903808179601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,35559,95,1.41 [0.66-3.02],0.3817511698244618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,34722,92,0.99 [0.47-2.09],0.978415389949614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,35624,95,1.35 [0.76-2.40],0.3057867718275473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,35624,95,1.01 [0.72-1.41],0.9623740117328063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,41140,112,0.87 [0.69-1.09],0.2131236632268076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,41042,112,1.39 [0.86-2.23],0.1817464134862854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPART,Spartin,34912,91,0.99 [0.76-1.29],0.9474206970912384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,35675,94,1.56 [0.85-2.87],0.1554126758434077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,41034,110,1.27 [0.85-1.89],0.2430399152976857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,34912,91,0.70 [0.39-1.24],0.2193420525435568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,40984,113,1.14 [0.89-1.46],0.3078774615450803
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,41034,110,0.92 [0.56-1.54],0.7611852280051555
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,41402,112,1.01 [0.84-1.22],0.8851140681895565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,34553,90,1.11 [0.68-1.81],0.6716576423457834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,40903,109,0.99 [0.50-1.98],0.9783805361350268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,41192,113,0.71 [0.48-1.04],0.078539511195095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,35524,95,1.01 [0.88-1.16],0.8715969031660042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,40726,108,1.05 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,41065,113,0.86 [0.51-1.46],0.5828777173018908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,41459,113,0.94 [0.65-1.34],0.7173553313911231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",34646,90,0.98 [0.62-1.55],0.9352251479839758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,34431,93,0.96 [0.69-1.34],0.8051742498625797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,35024,96,0.96 [0.76-1.22],0.7536148716261428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,35607,94,1.10 [0.83-1.46],0.5132485800797164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,40296,112,0.83 [0.69-1.01],0.0575438919038337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34583,90,0.85 [0.44-1.63],0.619079172923115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,35607,94,1.17 [0.74-1.85],0.5052918365480044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,41071,112,0.99 [0.86-1.14],0.8872968880403995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,40836,112,1.15 [0.72-1.86],0.5566368752957606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,40984,113,0.86 [0.69-1.06],0.1658634793536229
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,35675,94,0.94 [0.54-1.63],0.8141406864480004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,40075,112,0.77 [0.55-1.09],0.139357421673717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",34646,90,1.19 [0.71-1.98],0.5045648038958965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41179,112,0.84 [0.58-1.20],0.3332929065219649
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,34431,93,0.68 [0.33-1.43],0.3134590086437416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,35524,95,0.78 [0.53-1.17],0.2331860865463776
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,34912,91,1.03 [0.72-1.48],0.8690645271977053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40836,112,0.87 [0.57-1.33],0.5220723482628165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",34646,90,1.14 [0.80-1.62],0.470090925276118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,35680,94,0.64 [0.33-1.25],0.1955267114939783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,35515,96,0.73 [0.41-1.29],0.2734703969212845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,40650,108,0.93 [0.71-1.22],0.6024187157392034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,34646,90,0.84 [0.64-1.10],0.2036557475349265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,40836,112,0.97 [0.86-1.10],0.6830049434223513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,34431,93,0.75 [0.53-1.07],0.1184326698284795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41391,112,1.27 [0.85-1.90],0.2486559801792226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,40979,110,1.49 [0.75-2.96],0.2539056321223605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,34583,90,1.16 [0.92-1.45],0.2176952286983245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,40969,110,1.00 [0.78-1.30],0.9721678292436432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,40303,112,0.94 [0.79-1.12],0.5020061296685852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,40075,112,0.92 [0.70-1.21],0.5416029986596698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",34431,93,0.86 [0.67-1.08],0.1973080578119076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,40101,112,1.04 [0.78-1.38],0.8016163694029664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,34722,92,1.17 [0.77-1.77],0.45434728694444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,35607,94,0.96 [0.58-1.59],0.8670539045137441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,40836,112,0.91 [0.68-1.22],0.5220388796095663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,34646,90,1.25 [0.85-1.86],0.2575069434370565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,40101,112,0.78 [0.58-1.03],0.0839575645798145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,34646,90,1.07 [0.72-1.61],0.7277850828254636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,40984,113,0.81 [0.57-1.16],0.2573855005839595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,35624,95,0.89 [0.70-1.15],0.3833478801612013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,40101,112,0.80 [0.53-1.21],0.2947538556547502
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,35524,95,0.99 [0.61-1.61],0.9684360668509212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,40101,112,0.93 [0.75-1.16],0.5368437732611855
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,41391,112,0.99 [0.87-1.13],0.9376433222332596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,40984,113,1.11 [0.86-1.44],0.4334275933401004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,34646,90,1.00 [0.74-1.34],0.978340360606815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41391,112,0.93 [0.68-1.27],0.6603244701035467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",35624,95,1.01 [0.74-1.38],0.930293767517488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,40303,112,0.98 [0.69-1.39],0.9193143926603612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,41034,110,1.05 [0.58-1.88],0.8830372381000223
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,35515,96,1.26 [0.83-1.92],0.2771203086344872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,34725,91,1.48 [0.81-2.70],0.2019291250219986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,34722,92,0.96 [0.69-1.33],0.7905364090008944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,35524,95,0.51 [0.27-0.96],0.0366380792795377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,34912,91,0.80 [0.55-1.17],0.2488532522360276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,34583,90,1.08 [0.78-1.51],0.6470075422331587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,35607,94,0.91 [0.54-1.54],0.720369609599871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,35675,94,0.93 [0.71-1.23],0.6135501375059265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,35024,96,0.95 [0.79-1.15],0.6171363407949277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,40836,112,0.96 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,35515,96,0.60 [0.36-0.99],0.0476490342613829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,40836,112,0.97 [0.59-1.58],0.891774421498609
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,34431,93,0.93 [0.66-1.30],0.6584146751058474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,35549,94,0.98 [0.63-1.52],0.938285428536758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,40296,112,0.95 [0.74-1.21],0.6720455625167574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,35024,96,0.94 [0.66-1.34],0.7467849957609757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,40075,112,0.96 [0.78-1.19],0.7428008826929182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",34722,92,0.79 [0.58-1.09],0.1501640374674121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",35515,96,0.84 [0.50-1.44],0.532578689284266
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,35607,94,0.87 [0.63-1.20],0.4006147498628398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,40075,112,1.16 [0.82-1.65],0.3962534217525636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,40836,112,1.00 [0.83-1.20],0.963684297185768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,40984,113,1.02 [0.83-1.26],0.8417070423523744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,34912,91,0.98 [0.78-1.25],0.892918580660672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,40726,108,0.95 [0.80-1.12],0.5527237919946353
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,40726,108,0.89 [0.72-1.10],0.2957513712244031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,40101,112,0.91 [0.75-1.11],0.3752152381158731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,34722,92,0.83 [0.51-1.35],0.4421001372061116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,40664,108,1.02 [0.86-1.22],0.7880798599122121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,40303,112,0.90 [0.71-1.15],0.3966903077536853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,34973,93,0.88 [0.48-1.62],0.6906208627515238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,41459,113,1.01 [0.59-1.73],0.9656469164264138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,35675,94,1.46 [0.86-2.47],0.1642817967203556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,35024,96,1.18 [0.90-1.54],0.2442142749871437
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,35675,94,0.66 [0.34-1.27],0.2130984731853086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,40075,112,1.04 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",34722,92,0.44 [0.22-0.88],0.0195443159827022
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,35515,96,0.99 [0.76-1.29],0.9421477457880252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,40075,112,0.81 [0.65-1.00],0.0517375732529741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,34553,90,0.82 [0.50-1.36],0.4388516187157331
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,41140,112,1.53 [0.72-3.28],0.2720834582946932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,34646,90,0.93 [0.47-1.87],0.8434812852133705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,34959,96,0.87 [0.68-1.10],0.2343565932114694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,34722,92,1.11 [0.74-1.67],0.6057656482355355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,35024,96,1.51 [1.13-2.02],0.0058640138103631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,35728,94,1.01 [0.41-2.50],0.983341532667176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,34583,90,1.24 [0.95-1.63],0.1150188582968129
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,40848,110,1.00 [0.91-1.10],0.9684953968520352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,41132,113,1.04 [0.77-1.40],0.7884028787816294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,40993,112,1.05 [0.73-1.52],0.7783751907787283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,40920,111,0.89 [0.50-1.57],0.6848279434618494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,41014,112,0.89 [0.55-1.43],0.6257651234601643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,41192,112,1.67 [1.13-2.48],0.010213693240612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,35515,96,1.01 [0.85-1.20],0.9277926437437434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,40984,113,0.70 [0.48-1.03],0.0695671737634832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,41424,113,1.02 [0.66-1.58],0.9255627972571752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,35515,96,0.93 [0.64-1.36],0.7238558636750434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,40786,111,0.81 [0.43-1.53],0.5179428762695863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,34646,90,0.68 [0.26-1.81],0.4402643180504302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41140,112,1.28 [1.28-1.28],0.0
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,41529,114,1.12 [0.66-1.91],0.6709554781096608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,40965,111,1.26 [1.01-1.56],0.040109297303741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,35700,95,2.27 [1.11-4.63],0.0246462808659544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,34366,93,1.16 [0.96-1.39],0.1210944086325605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,41034,110,0.89 [0.55-1.43],0.6241232510171838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,41047,111,0.91 [0.65-1.26],0.564425186414284
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,40303,112,1.05 [0.68-1.62],0.834315621398057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,34553,90,0.94 [0.77-1.15],0.5541601746944926
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,34384,90,0.89 [0.48-1.63],0.6955960096892508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,35449,96,0.94 [0.75-1.18],0.5996092510608403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,41391,112,1.31 [0.74-2.33],0.34916079359148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,39857,110,0.94 [0.81-1.08],0.3781073555587317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,41529,114,0.97 [0.64-1.47],0.8890890494804387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39999,112,0.84 [0.59-1.21],0.3594468068780022
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35024,96,1.26 [0.80-2.01],0.321660678558147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41179,112,1.33 [0.91-1.94],0.1355325941288451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,35675,94,0.67 [0.39-1.14],0.1372146482502922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,35607,94,1.01 [0.81-1.27],0.9059685540653076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,40587,111,0.91 [0.49-1.66],0.7494195430670004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,35675,94,0.59 [0.23-1.49],0.2620746350563587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,41192,113,0.94 [0.83-1.07],0.3722759440729464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,41034,110,0.85 [0.55-1.30],0.4508303975185519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,41140,112,0.96 [0.79-1.18],0.6985170829727344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,34583,90,1.10 [0.71-1.71],0.6731115563808614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",35024,96,0.83 [0.51-1.33],0.4312003035623706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,34646,90,1.45 [0.70-3.02],0.3219605861732099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,35024,96,1.13 [0.49-2.63],0.7712934431191775
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,41497,113,1.10 [0.87-1.40],0.4193044238454112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,34646,90,1.39 [0.72-2.71],0.3271123563346538
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,34722,92,0.99 [0.69-1.44],0.971657099833113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,35024,96,0.94 [0.65-1.36],0.7324883767219303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,34553,90,0.97 [0.64-1.48],0.9027421957629876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,34553,90,0.88 [0.59-1.31],0.5267777374232244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,35524,95,0.92 [0.76-1.12],0.4113869276283912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,35515,96,0.99 [0.75-1.31],0.9443369661656784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,34734,94,1.22 [0.90-1.66],0.194485702449127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,35624,95,1.24 [0.86-1.79],0.247086074923051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,34431,93,0.93 [0.56-1.54],0.7771309515977469
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,34583,90,0.71 [0.51-1.00],0.0522867844338073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,35534,94,1.06 [0.64-1.77],0.8086548366803221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,40836,112,0.97 [0.81-1.17],0.7595902527131307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,40530,108,1.37 [0.87-2.15],0.1759268917298055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,41034,110,0.89 [0.75-1.06],0.1867638269450185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,41179,112,0.82 [0.58-1.17],0.2795114534288346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,40237,112,1.01 [0.66-1.54],0.9737206689626744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,35524,95,0.92 [0.60-1.39],0.6783191149832927
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40296,112,0.78 [0.49-1.24],0.289825958761212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,34912,91,0.77 [0.55-1.08],0.1361845504617057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40726,108,1.28 [0.77-2.12],0.3411536699820233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40726,108,0.91 [0.41-2.01],0.8087240583417765
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41105,113,0.97 [0.70-1.36],0.8726271745974021
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41497,113,1.12 [0.64-1.95],0.6963042296970104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40992,112,1.45 [0.84-2.50],0.1834402799236596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41140,112,1.36 [0.79-2.34],0.2724984788747023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41065,113,0.82 [0.58-1.15],0.2422548367267034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40296,112,0.88 [0.57-1.37],0.5805876428501047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41065,113,0.92 [0.52-1.62],0.7613433744725686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,34912,91,0.59 [0.37-0.97],0.036222418208605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41402,112,1.36 [0.75-2.46],0.3066009181284759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41034,110,0.94 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41034,110,1.11 [0.71-1.72],0.6544148962193934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41391,112,1.04 [0.56-1.92],0.8999176166763357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41424,113,1.14 [0.74-1.77],0.5520547625616117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40726,108,0.77 [0.56-1.05],0.0970163480750626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41391,112,0.98 [0.68-1.42],0.9321235549656064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40726,108,1.20 [1.18-1.22],2.115215285338523e-74
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,41497,113,1.23 [0.64-2.33],0.5343497177943091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,40984,113,0.93 [0.71-1.23],0.6170334476957859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,41497,113,0.78 [0.43-1.42],0.4148327416915641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,41192,113,1.33 [0.71-2.50],0.3754553276094773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41459,114,1.14 [0.73-1.79],0.5670084422092811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,40726,108,0.89 [0.65-1.20],0.4288276798227464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35680,94,1.33 [0.78-2.27],0.2969422145716652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,35607,94,0.98 [0.78-1.22],0.8463447680904059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,35680,94,0.92 [0.59-1.44],0.7174694523203768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",40303,112,1.01 [0.83-1.23],0.9147533267339788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,35024,96,1.04 [0.60-1.80],0.8888779808175934
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,40726,108,1.29 [0.86-1.92],0.2166820363679322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,41034,110,0.78 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,35675,94,0.91 [0.70-1.19],0.4901360433491821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,35524,95,0.97 [0.81-1.15],0.7135490813200681
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",34431,93,0.98 [0.65-1.48],0.916273630776612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,34646,90,1.02 [0.79-1.32],0.8526113279919976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,34734,94,1.12 [0.80-1.58],0.5012295772699047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,40101,112,0.88 [0.59-1.31],0.5231112825961395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,34646,90,0.99 [0.79-1.24],0.9169285929700026
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,34147,88,1.01 [0.68-1.50],0.9508800266165244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,40303,112,1.16 [0.73-1.85],0.5239504707723841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,34722,92,1.23 [0.69-2.20],0.4852758141862902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,34722,92,1.00 [0.62-1.61],0.9953970785453466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,34912,91,0.93 [0.78-1.12],0.4705330710140863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,35675,94,0.60 [0.29-1.24],0.1688995863741056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,34553,90,1.27 [0.86-1.89],0.2306373259582551
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,40101,112,0.96 [0.76-1.22],0.7556122789482247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,40733,112,0.68 [0.51-0.90],0.0067033005223435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,35024,96,0.81 [0.61-1.08],0.1492321250783488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,40075,112,0.75 [0.46-1.22],0.2477240709553345
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,34553,90,1.29 [0.97-1.72],0.0832827734653916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,34431,93,0.88 [0.62-1.24],0.4654548400113397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,41433,112,0.98 [0.71-1.35],0.9116302590309086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,35624,95,0.91 [0.53-1.58],0.7489936074265325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,34646,90,1.32 [0.67-2.60],0.4239069822091451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,40296,112,0.91 [0.69-1.21],0.525616167955935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,40984,113,1.04 [0.88-1.22],0.676372400369767
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",34646,90,1.25 [0.79-1.99],0.3444016071189039
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,34553,90,0.89 [0.56-1.41],0.6184796249964744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,35024,96,0.97 [0.77-1.23],0.8087706610283676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,35680,94,1.01 [0.78-1.32],0.9354558158839122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,40992,112,1.12 [0.82-1.53],0.4680355749269881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,35700,95,0.88 [0.60-1.28],0.5049291472785448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,41034,110,1.00 [0.60-1.67],0.987686094259618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,41402,112,0.96 [0.74-1.26],0.7762910068409147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,40984,113,0.91 [0.74-1.12],0.365378940746401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,34954,96,1.21 [0.92-1.59],0.1692441165582534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,35524,95,0.98 [0.82-1.18],0.8393596744214055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,34431,93,0.97 [0.68-1.38],0.8772222961027568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,34722,92,0.78 [0.58-1.05],0.0971869381752672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,40984,113,0.89 [0.73-1.08],0.2336165131690524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,35515,96,1.03 [0.82-1.29],0.8192570745627957
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,34553,90,0.98 [0.65-1.49],0.9393503953900716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,34646,90,0.75 [0.53-1.06],0.1034119206408062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,35624,95,0.76 [0.56-1.05],0.097154533098491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,40303,112,0.88 [0.64-1.19],0.3995101438146782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,34553,90,1.04 [0.63-1.73],0.8809983772188947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,40303,112,1.01 [0.75-1.36],0.9682747552467292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,34553,90,0.74 [0.45-1.20],0.2198874181566442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,34583,90,0.87 [0.68-1.11],0.2482718587993477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,35524,95,0.90 [0.74-1.10],0.3230957014302704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,34646,90,0.76 [0.45-1.30],0.320625716480766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,40007,111,0.88 [0.70-1.10],0.259609075220347
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,34722,92,0.77 [0.50-1.18],0.2234460950578979
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTN,Titin,34553,90,0.99 [0.74-1.32],0.9365646702005804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,35338,92,1.24 [0.56-2.78],0.5944907124275296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,34583,90,0.70 [0.33-1.46],0.3377202280894152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,35680,94,0.92 [0.73-1.17],0.4929625064739008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,35024,96,0.97 [0.75-1.26],0.8114361483334004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,40726,108,0.92 [0.78-1.08],0.3221703867957579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,35103,94,1.00 [0.64-1.56],0.9948668102045004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,41140,112,0.69 [0.38-1.25],0.220461078950399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,41391,112,0.91 [0.71-1.17],0.4834596431856834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,35607,94,0.80 [0.54-1.20],0.2849836391717104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,34520,90,0.95 [0.77-1.17],0.616924365261277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41034,110,0.85 [0.58-1.24],0.3953604497063691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",34646,90,1.26 [0.90-1.77],0.1735752450097766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,40836,112,1.33 [0.82-2.15],0.2461392016531984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,35515,96,0.85 [0.43-1.67],0.6320092075358079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,35675,94,0.98 [0.71-1.35],0.907015654906771
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,34646,90,0.76 [0.51-1.12],0.1682886096246214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,34553,90,1.13 [0.78-1.64],0.5049154060342995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,34912,91,0.92 [0.68-1.24],0.5703972347262389
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,35524,95,0.94 [0.82-1.09],0.426510725666858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,34553,90,0.99 [0.80-1.21],0.8879679197151443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,34553,90,0.82 [0.43-1.56],0.5488052434097367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,40726,108,1.19 [0.77-1.85],0.4295341229479246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,41401,114,0.89 [0.64-1.23],0.4715365119870893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,34646,90,1.75 [0.91-3.33],0.0909031051101651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,34431,93,0.75 [0.51-1.11],0.1534381446692247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,35515,96,0.95 [0.54-1.69],0.8741958063066809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,35675,94,1.11 [0.89-1.37],0.3516629478003545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,34583,90,1.17 [0.80-1.71],0.4214176000808696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,34958,96,0.60 [0.35-1.02],0.0584937424908122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,34912,91,0.83 [0.62-1.12],0.2243193518722421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,34722,92,1.14 [0.88-1.49],0.3309362170855217
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,40836,112,0.91 [0.76-1.10],0.345458858212382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,35515,96,0.89 [0.68-1.17],0.4032804007772322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,35607,94,0.75 [0.40-1.39],0.3634755746258772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,34553,90,0.87 [0.67-1.13],0.2939425921314085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,40303,112,0.91 [0.76-1.10],0.3323818693391651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,40101,112,0.60 [0.43-0.84],0.0030970159671337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,40303,112,0.57 [0.43-0.77],0.00020726691932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,34646,90,0.97 [0.77-1.22],0.7903864268083015
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,40984,113,0.84 [0.68-1.04],0.1096410076605738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,40374,111,0.87 [0.47-1.62],0.6636865124043899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,35700,95,0.94 [0.71-1.23],0.6517021747917653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40836,112,0.55 [0.25-1.22],0.1428237759582565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,34583,90,0.97 [0.79-1.20],0.7987156027614037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41120,112,1.18 [0.63-2.22],0.5975320706390541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,41391,112,1.00 [0.57-1.74],0.996872017005674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,34431,93,0.88 [0.68-1.15],0.3658361488958295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,41373,113,0.88 [0.66-1.18],0.4031884057487355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,34646,90,0.61 [0.30-1.25],0.1799052419947562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,41140,112,0.85 [0.67-1.07],0.1649239607250827
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,41430,113,1.10 [0.69-1.73],0.6958008598520727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,35624,95,1.68 [0.89-3.15],0.1074602070173162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,40303,112,1.01 [0.88-1.17],0.8657527194662258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,34734,94,1.24 [0.60-2.56],0.5623724187906396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,35675,94,0.56 [0.33-0.95],0.0301039730422986
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,40836,112,0.93 [0.74-1.18],0.5639153223822037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,35700,95,1.03 [0.79-1.36],0.815978498386047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,40836,112,0.95 [0.66-1.36],0.7644693868739088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,35024,96,0.86 [0.63-1.17],0.3473707086892414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,40836,112,0.93 [0.76-1.15],0.5278817483313092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,35515,96,0.89 [0.72-1.10],0.2716443549363034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,40836,112,0.93 [0.74-1.16],0.5020100488955801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,35515,96,0.93 [0.52-1.67],0.8087183813308467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,34553,90,0.77 [0.40-1.47],0.4310263108635621
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,35515,96,1.19 [0.87-1.63],0.2708468943777261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,40979,110,0.94 [0.64-1.37],0.7452302223607907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,35607,94,0.88 [0.51-1.52],0.6529381378828901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,40075,112,0.68 [0.49-0.95],0.0247026489003534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,35024,96,1.10 [0.72-1.68],0.6531965698089715
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40303,112,1.12 [0.86-1.46],0.3930680429921294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41391,112,0.84 [0.66-1.06],0.14569220677067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,40101,112,1.25 [0.74-2.12],0.397685332420774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,34912,91,0.81 [0.56-1.17],0.2601261664311481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,41340,112,0.84 [0.36-1.95],0.681063604091783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,34431,93,0.97 [0.75-1.26],0.8359076408696245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,40581,108,0.78 [0.51-1.20],0.2604872870557587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,35624,95,0.54 [0.29-1.01],0.0526102865199429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,41529,114,1.14 [1.03-1.25],0.0104733303265395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",41034,110,0.89 [0.57-1.39],0.6100532390544628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,40296,112,0.99 [0.77-1.27],0.935208620376374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,40303,112,1.03 [0.86-1.23],0.7300682001780132
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,40075,112,1.02 [0.84-1.25],0.8194996432028078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,35607,94,0.93 [0.71-1.21],0.567467078090746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,34646,90,1.02 [0.74-1.42],0.8897133763280242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,35515,96,1.04 [0.61-1.77],0.8803307896504242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,34795,96,0.92 [0.62-1.35],0.6552262536121964
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,41339,112,1.05 [0.80-1.37],0.7461836221326699
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,38926,102,1.27 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40597,108,1.12 [0.74-1.70],0.5883626138850524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41065,113,0.99 [0.62-1.58],0.96465024213807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,41402,112,0.70 [0.43-1.15],0.1586762446340729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,40296,112,1.62 [1.04-2.53],0.0324016824924933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40726,108,0.84 [0.61-1.17],0.3029220042324354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,41402,112,1.21 [0.94-1.56],0.1328447895992648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,41327,114,1.29 [0.79-2.11],0.307603824964952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,34646,90,0.90 [0.63-1.30],0.5824401162238604
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,41140,112,1.07 [0.76-1.52],0.6876219421234733
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,40075,112,0.62 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,35607,94,0.85 [0.40-1.81],0.6694737117377028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",35524,95,0.96 [0.84-1.10],0.554222975214177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,40836,112,0.94 [0.82-1.09],0.4422080321706086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,35515,96,0.69 [0.37-1.30],0.2523096835076156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,34553,90,1.14 [0.83-1.57],0.4121290825384566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,40296,112,0.94 [0.77-1.15],0.5699883432947302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,34912,91,0.91 [0.69-1.20],0.5097013154406738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,34646,90,0.94 [0.45-1.94],0.8635056179691065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,34646,90,0.99 [0.61-1.63],0.9807230573725572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,40101,112,0.84 [0.65-1.09],0.197805426127356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40303,112,1.06 [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,34553,90,1.02 [0.74-1.41],0.9059461056898628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,35524,95,0.82 [0.66-1.02],0.0725383900216443
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,35607,94,1.26 [0.80-2.00],0.3214443452907298
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,34646,90,1.01 [0.59-1.72],0.9746214099644442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,35024,96,1.15 [0.87-1.51],0.3281792094208633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,35515,96,1.17 [0.94-1.44],0.1600258795419412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,35524,95,0.90 [0.67-1.21],0.4906954982296523
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,35515,96,0.90 [0.62-1.31],0.5841075244821378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,34734,94,0.97 [0.90-1.04],0.4339834617381033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,34431,93,0.95 [0.51-1.78],0.8705316767725328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,34583,90,0.92 [0.72-1.16],0.462975251741011
